PubMed:23580777 JSONTXT

Annnotations TAB JSON ListView MergeView

    Glycan-Motif

    {"project":"Glycan-Motif","denotations":[{"id":"T1","span":{"begin":0,"end":8},"obj":"https://glytoucan.org/Structures/Glycans/G49108TO"},{"id":"T2","span":{"begin":0,"end":8},"obj":"https://glytoucan.org/Structures/Glycans/G89565QL"},{"id":"T3","span":{"begin":311,"end":319},"obj":"https://glytoucan.org/Structures/Glycans/G49108TO"},{"id":"T4","span":{"begin":311,"end":319},"obj":"https://glytoucan.org/Structures/Glycans/G89565QL"},{"id":"T5","span":{"begin":366,"end":374},"obj":"https://glytoucan.org/Structures/Glycans/G49108TO"},{"id":"T6","span":{"begin":366,"end":374},"obj":"https://glytoucan.org/Structures/Glycans/G89565QL"},{"id":"T7","span":{"begin":1018,"end":1026},"obj":"https://glytoucan.org/Structures/Glycans/G49108TO"},{"id":"T8","span":{"begin":1018,"end":1026},"obj":"https://glytoucan.org/Structures/Glycans/G89565QL"},{"id":"T9","span":{"begin":1152,"end":1160},"obj":"https://glytoucan.org/Structures/Glycans/G49108TO"},{"id":"T10","span":{"begin":1152,"end":1160},"obj":"https://glytoucan.org/Structures/Glycans/G89565QL"},{"id":"T11","span":{"begin":1404,"end":1412},"obj":"https://glytoucan.org/Structures/Glycans/G49108TO"},{"id":"T12","span":{"begin":1404,"end":1412},"obj":"https://glytoucan.org/Structures/Glycans/G89565QL"},{"id":"T13","span":{"begin":1476,"end":1484},"obj":"https://glytoucan.org/Structures/Glycans/G49108TO"},{"id":"T14","span":{"begin":1476,"end":1484},"obj":"https://glytoucan.org/Structures/Glycans/G89565QL"}],"text":"O-GlcNAc transferase inhibits KSHV propagation and modifies replication relevant viral proteins as detected by systematic O-GlcNAcylation analysis.\nO-GlcNAcylation is an inducible, highly dynamic and reversible post-translational modification, mediated by a unique enzyme named O-linked N-acetyl-d-glucosamine (O-GlcNAc) transferase (OGT). In response to nutrients, O-GlcNAc levels are differentially regulated on many cellular proteins involved in gene expression, translation, immune reactions, protein degradation, protein-protein interaction, apoptosis and signal transduction. In contrast to eukaryotic cells, little is known about the role of O-GlcNAcylation in the viral life cycle. Here, we show that the overexpression of the OGT reduces the replication efficiency of Kaposi's sarcoma-associated herpesvirus (KSHV) in a dose-dependent manner. In order to investigate the global impact of O-GlcNAcylation in the KSHV life cycle, we systematically analyzed the 85 annotated KSHV-encoded open reading frames for O-GlcNAc modification. For this purpose, an immunoprecipitation (IP) strategy with three different approaches was carried out and the O-GlcNAc signal of the identified proteins was properly controlled for specificity. Out of the 85 KSHV-encoded proteins, 18 proteins were found to be direct targets for O-GlcNAcylation. Selected proteins were further confirmed by mass spectrometry for O-GlcNAc modification. Correlation of the functional annotation and the O-GlcNAc status of KSHV proteins showed that the predominant targets were proteins involved in viral DNA synthesis and replication. These results indicate that O-GlcNAcylation plays a major role in the regulation of KSHV propagation."}

    GlyCosmos6-Glycan-Motif-Image

    {"project":"GlyCosmos6-Glycan-Motif-Image","denotations":[{"id":"T1","span":{"begin":0,"end":8},"obj":"Glycan_Motif"},{"id":"T3","span":{"begin":311,"end":319},"obj":"Glycan_Motif"},{"id":"T5","span":{"begin":366,"end":374},"obj":"Glycan_Motif"},{"id":"T7","span":{"begin":1018,"end":1026},"obj":"Glycan_Motif"},{"id":"T9","span":{"begin":1152,"end":1160},"obj":"Glycan_Motif"},{"id":"T11","span":{"begin":1404,"end":1412},"obj":"Glycan_Motif"},{"id":"T13","span":{"begin":1476,"end":1484},"obj":"Glycan_Motif"}],"attributes":[{"id":"A1","pred":"image","subj":"T1","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G89565QL"},{"id":"A2","pred":"image","subj":"T1","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G49108TO"},{"id":"A3","pred":"image","subj":"T3","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G89565QL"},{"id":"A4","pred":"image","subj":"T3","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G49108TO"},{"id":"A5","pred":"image","subj":"T5","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G89565QL"},{"id":"A6","pred":"image","subj":"T5","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G49108TO"},{"id":"A7","pred":"image","subj":"T7","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G89565QL"},{"id":"A8","pred":"image","subj":"T7","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G49108TO"},{"id":"A9","pred":"image","subj":"T9","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G89565QL"},{"id":"A10","pred":"image","subj":"T9","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G49108TO"},{"id":"A11","pred":"image","subj":"T11","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G89565QL"},{"id":"A12","pred":"image","subj":"T11","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G49108TO"},{"id":"A13","pred":"image","subj":"T13","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G89565QL"},{"id":"A14","pred":"image","subj":"T13","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G49108TO"}],"text":"O-GlcNAc transferase inhibits KSHV propagation and modifies replication relevant viral proteins as detected by systematic O-GlcNAcylation analysis.\nO-GlcNAcylation is an inducible, highly dynamic and reversible post-translational modification, mediated by a unique enzyme named O-linked N-acetyl-d-glucosamine (O-GlcNAc) transferase (OGT). In response to nutrients, O-GlcNAc levels are differentially regulated on many cellular proteins involved in gene expression, translation, immune reactions, protein degradation, protein-protein interaction, apoptosis and signal transduction. In contrast to eukaryotic cells, little is known about the role of O-GlcNAcylation in the viral life cycle. Here, we show that the overexpression of the OGT reduces the replication efficiency of Kaposi's sarcoma-associated herpesvirus (KSHV) in a dose-dependent manner. In order to investigate the global impact of O-GlcNAcylation in the KSHV life cycle, we systematically analyzed the 85 annotated KSHV-encoded open reading frames for O-GlcNAc modification. For this purpose, an immunoprecipitation (IP) strategy with three different approaches was carried out and the O-GlcNAc signal of the identified proteins was properly controlled for specificity. Out of the 85 KSHV-encoded proteins, 18 proteins were found to be direct targets for O-GlcNAcylation. Selected proteins were further confirmed by mass spectrometry for O-GlcNAc modification. Correlation of the functional annotation and the O-GlcNAc status of KSHV proteins showed that the predominant targets were proteins involved in viral DNA synthesis and replication. These results indicate that O-GlcNAcylation plays a major role in the regulation of KSHV propagation."}

    sentences

    {"project":"sentences","denotations":[{"id":"TextSentencer_T1","span":{"begin":0,"end":147},"obj":"Sentence"},{"id":"TextSentencer_T2","span":{"begin":148,"end":339},"obj":"Sentence"},{"id":"TextSentencer_T3","span":{"begin":340,"end":581},"obj":"Sentence"},{"id":"TextSentencer_T4","span":{"begin":582,"end":689},"obj":"Sentence"},{"id":"TextSentencer_T5","span":{"begin":690,"end":851},"obj":"Sentence"},{"id":"TextSentencer_T6","span":{"begin":852,"end":1040},"obj":"Sentence"},{"id":"TextSentencer_T7","span":{"begin":1041,"end":1235},"obj":"Sentence"},{"id":"TextSentencer_T8","span":{"begin":1236,"end":1337},"obj":"Sentence"},{"id":"TextSentencer_T9","span":{"begin":1338,"end":1426},"obj":"Sentence"},{"id":"TextSentencer_T10","span":{"begin":1427,"end":1607},"obj":"Sentence"},{"id":"TextSentencer_T11","span":{"begin":1608,"end":1709},"obj":"Sentence"},{"id":"T1","span":{"begin":0,"end":147},"obj":"Sentence"},{"id":"T2","span":{"begin":148,"end":339},"obj":"Sentence"},{"id":"T3","span":{"begin":340,"end":581},"obj":"Sentence"},{"id":"T4","span":{"begin":582,"end":689},"obj":"Sentence"},{"id":"T5","span":{"begin":690,"end":851},"obj":"Sentence"},{"id":"T6","span":{"begin":852,"end":1040},"obj":"Sentence"},{"id":"T7","span":{"begin":1041,"end":1235},"obj":"Sentence"},{"id":"T8","span":{"begin":1236,"end":1337},"obj":"Sentence"},{"id":"T9","span":{"begin":1338,"end":1426},"obj":"Sentence"},{"id":"T10","span":{"begin":1427,"end":1607},"obj":"Sentence"},{"id":"T11","span":{"begin":1608,"end":1709},"obj":"Sentence"},{"id":"T1","span":{"begin":0,"end":147},"obj":"Sentence"},{"id":"T2","span":{"begin":148,"end":339},"obj":"Sentence"},{"id":"T3","span":{"begin":340,"end":581},"obj":"Sentence"},{"id":"T4","span":{"begin":582,"end":689},"obj":"Sentence"},{"id":"T5","span":{"begin":690,"end":851},"obj":"Sentence"},{"id":"T6","span":{"begin":852,"end":1040},"obj":"Sentence"},{"id":"T7","span":{"begin":1041,"end":1235},"obj":"Sentence"},{"id":"T8","span":{"begin":1236,"end":1337},"obj":"Sentence"},{"id":"T9","span":{"begin":1338,"end":1426},"obj":"Sentence"},{"id":"T10","span":{"begin":1427,"end":1607},"obj":"Sentence"},{"id":"T11","span":{"begin":1608,"end":1709},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"O-GlcNAc transferase inhibits KSHV propagation and modifies replication relevant viral proteins as detected by systematic O-GlcNAcylation analysis.\nO-GlcNAcylation is an inducible, highly dynamic and reversible post-translational modification, mediated by a unique enzyme named O-linked N-acetyl-d-glucosamine (O-GlcNAc) transferase (OGT). In response to nutrients, O-GlcNAc levels are differentially regulated on many cellular proteins involved in gene expression, translation, immune reactions, protein degradation, protein-protein interaction, apoptosis and signal transduction. In contrast to eukaryotic cells, little is known about the role of O-GlcNAcylation in the viral life cycle. Here, we show that the overexpression of the OGT reduces the replication efficiency of Kaposi's sarcoma-associated herpesvirus (KSHV) in a dose-dependent manner. In order to investigate the global impact of O-GlcNAcylation in the KSHV life cycle, we systematically analyzed the 85 annotated KSHV-encoded open reading frames for O-GlcNAc modification. For this purpose, an immunoprecipitation (IP) strategy with three different approaches was carried out and the O-GlcNAc signal of the identified proteins was properly controlled for specificity. Out of the 85 KSHV-encoded proteins, 18 proteins were found to be direct targets for O-GlcNAcylation. Selected proteins were further confirmed by mass spectrometry for O-GlcNAc modification. Correlation of the functional annotation and the O-GlcNAc status of KSHV proteins showed that the predominant targets were proteins involved in viral DNA synthesis and replication. These results indicate that O-GlcNAcylation plays a major role in the regulation of KSHV propagation."}

    GlyCosmos6-Glycan-Motif-Structure

    {"project":"GlyCosmos6-Glycan-Motif-Structure","denotations":[{"id":"T1","span":{"begin":0,"end":8},"obj":"https://glytoucan.org/Structures/Glycans/G49108TO"},{"id":"T2","span":{"begin":0,"end":8},"obj":"https://glytoucan.org/Structures/Glycans/G89565QL"},{"id":"T3","span":{"begin":311,"end":319},"obj":"https://glytoucan.org/Structures/Glycans/G49108TO"},{"id":"T4","span":{"begin":311,"end":319},"obj":"https://glytoucan.org/Structures/Glycans/G89565QL"},{"id":"T5","span":{"begin":366,"end":374},"obj":"https://glytoucan.org/Structures/Glycans/G49108TO"},{"id":"T6","span":{"begin":366,"end":374},"obj":"https://glytoucan.org/Structures/Glycans/G89565QL"},{"id":"T7","span":{"begin":1018,"end":1026},"obj":"https://glytoucan.org/Structures/Glycans/G49108TO"},{"id":"T8","span":{"begin":1018,"end":1026},"obj":"https://glytoucan.org/Structures/Glycans/G89565QL"},{"id":"T9","span":{"begin":1152,"end":1160},"obj":"https://glytoucan.org/Structures/Glycans/G49108TO"},{"id":"T10","span":{"begin":1152,"end":1160},"obj":"https://glytoucan.org/Structures/Glycans/G89565QL"},{"id":"T11","span":{"begin":1404,"end":1412},"obj":"https://glytoucan.org/Structures/Glycans/G49108TO"},{"id":"T12","span":{"begin":1404,"end":1412},"obj":"https://glytoucan.org/Structures/Glycans/G89565QL"},{"id":"T13","span":{"begin":1476,"end":1484},"obj":"https://glytoucan.org/Structures/Glycans/G49108TO"},{"id":"T14","span":{"begin":1476,"end":1484},"obj":"https://glytoucan.org/Structures/Glycans/G89565QL"}],"text":"O-GlcNAc transferase inhibits KSHV propagation and modifies replication relevant viral proteins as detected by systematic O-GlcNAcylation analysis.\nO-GlcNAcylation is an inducible, highly dynamic and reversible post-translational modification, mediated by a unique enzyme named O-linked N-acetyl-d-glucosamine (O-GlcNAc) transferase (OGT). In response to nutrients, O-GlcNAc levels are differentially regulated on many cellular proteins involved in gene expression, translation, immune reactions, protein degradation, protein-protein interaction, apoptosis and signal transduction. In contrast to eukaryotic cells, little is known about the role of O-GlcNAcylation in the viral life cycle. Here, we show that the overexpression of the OGT reduces the replication efficiency of Kaposi's sarcoma-associated herpesvirus (KSHV) in a dose-dependent manner. In order to investigate the global impact of O-GlcNAcylation in the KSHV life cycle, we systematically analyzed the 85 annotated KSHV-encoded open reading frames for O-GlcNAc modification. For this purpose, an immunoprecipitation (IP) strategy with three different approaches was carried out and the O-GlcNAc signal of the identified proteins was properly controlled for specificity. Out of the 85 KSHV-encoded proteins, 18 proteins were found to be direct targets for O-GlcNAcylation. Selected proteins were further confirmed by mass spectrometry for O-GlcNAc modification. Correlation of the functional annotation and the O-GlcNAc status of KSHV proteins showed that the predominant targets were proteins involved in viral DNA synthesis and replication. These results indicate that O-GlcNAcylation plays a major role in the regulation of KSHV propagation."}

    Glycosmos6-GlycoEpitope

    {"project":"Glycosmos6-GlycoEpitope","denotations":[{"id":"T1","span":{"begin":0,"end":8},"obj":"http://www.glycoepitope.jp/epitopes/EP0004"},{"id":"T2","span":{"begin":311,"end":319},"obj":"http://www.glycoepitope.jp/epitopes/EP0004"},{"id":"T3","span":{"begin":366,"end":374},"obj":"http://www.glycoepitope.jp/epitopes/EP0004"},{"id":"T4","span":{"begin":1018,"end":1026},"obj":"http://www.glycoepitope.jp/epitopes/EP0004"},{"id":"T5","span":{"begin":1152,"end":1160},"obj":"http://www.glycoepitope.jp/epitopes/EP0004"},{"id":"T6","span":{"begin":1404,"end":1412},"obj":"http://www.glycoepitope.jp/epitopes/EP0004"},{"id":"T7","span":{"begin":1476,"end":1484},"obj":"http://www.glycoepitope.jp/epitopes/EP0004"}],"text":"O-GlcNAc transferase inhibits KSHV propagation and modifies replication relevant viral proteins as detected by systematic O-GlcNAcylation analysis.\nO-GlcNAcylation is an inducible, highly dynamic and reversible post-translational modification, mediated by a unique enzyme named O-linked N-acetyl-d-glucosamine (O-GlcNAc) transferase (OGT). In response to nutrients, O-GlcNAc levels are differentially regulated on many cellular proteins involved in gene expression, translation, immune reactions, protein degradation, protein-protein interaction, apoptosis and signal transduction. In contrast to eukaryotic cells, little is known about the role of O-GlcNAcylation in the viral life cycle. Here, we show that the overexpression of the OGT reduces the replication efficiency of Kaposi's sarcoma-associated herpesvirus (KSHV) in a dose-dependent manner. In order to investigate the global impact of O-GlcNAcylation in the KSHV life cycle, we systematically analyzed the 85 annotated KSHV-encoded open reading frames for O-GlcNAc modification. For this purpose, an immunoprecipitation (IP) strategy with three different approaches was carried out and the O-GlcNAc signal of the identified proteins was properly controlled for specificity. Out of the 85 KSHV-encoded proteins, 18 proteins were found to be direct targets for O-GlcNAcylation. Selected proteins were further confirmed by mass spectrometry for O-GlcNAc modification. Correlation of the functional annotation and the O-GlcNAc status of KSHV proteins showed that the predominant targets were proteins involved in viral DNA synthesis and replication. These results indicate that O-GlcNAcylation plays a major role in the regulation of KSHV propagation."}

    GlyCosmos15-Glycan

    {"project":"GlyCosmos15-Glycan","denotations":[{"id":"T1","span":{"begin":0,"end":8},"obj":"Glycan"},{"id":"T2","span":{"begin":311,"end":319},"obj":"Glycan"},{"id":"T3","span":{"begin":366,"end":374},"obj":"Glycan"},{"id":"T4","span":{"begin":1018,"end":1026},"obj":"Glycan"},{"id":"T5","span":{"begin":1152,"end":1160},"obj":"Glycan"},{"id":"T6","span":{"begin":1404,"end":1412},"obj":"Glycan"},{"id":"T7","span":{"begin":1476,"end":1484},"obj":"Glycan"}],"attributes":[{"id":"A1","pred":"glycosmos_id","subj":"T1","obj":"https://glycosmos.org/glycans/show/G49108TO"},{"id":"A2","pred":"glycosmos_id","subj":"T2","obj":"https://glycosmos.org/glycans/show/G49108TO"},{"id":"A3","pred":"glycosmos_id","subj":"T3","obj":"https://glycosmos.org/glycans/show/G49108TO"},{"id":"A4","pred":"glycosmos_id","subj":"T4","obj":"https://glycosmos.org/glycans/show/G49108TO"},{"id":"A5","pred":"glycosmos_id","subj":"T5","obj":"https://glycosmos.org/glycans/show/G49108TO"},{"id":"A6","pred":"glycosmos_id","subj":"T6","obj":"https://glycosmos.org/glycans/show/G49108TO"},{"id":"A7","pred":"glycosmos_id","subj":"T7","obj":"https://glycosmos.org/glycans/show/G49108TO"}],"text":"O-GlcNAc transferase inhibits KSHV propagation and modifies replication relevant viral proteins as detected by systematic O-GlcNAcylation analysis.\nO-GlcNAcylation is an inducible, highly dynamic and reversible post-translational modification, mediated by a unique enzyme named O-linked N-acetyl-d-glucosamine (O-GlcNAc) transferase (OGT). In response to nutrients, O-GlcNAc levels are differentially regulated on many cellular proteins involved in gene expression, translation, immune reactions, protein degradation, protein-protein interaction, apoptosis and signal transduction. In contrast to eukaryotic cells, little is known about the role of O-GlcNAcylation in the viral life cycle. Here, we show that the overexpression of the OGT reduces the replication efficiency of Kaposi's sarcoma-associated herpesvirus (KSHV) in a dose-dependent manner. In order to investigate the global impact of O-GlcNAcylation in the KSHV life cycle, we systematically analyzed the 85 annotated KSHV-encoded open reading frames for O-GlcNAc modification. For this purpose, an immunoprecipitation (IP) strategy with three different approaches was carried out and the O-GlcNAc signal of the identified proteins was properly controlled for specificity. Out of the 85 KSHV-encoded proteins, 18 proteins were found to be direct targets for O-GlcNAcylation. Selected proteins were further confirmed by mass spectrometry for O-GlcNAc modification. Correlation of the functional annotation and the O-GlcNAc status of KSHV proteins showed that the predominant targets were proteins involved in viral DNA synthesis and replication. These results indicate that O-GlcNAcylation plays a major role in the regulation of KSHV propagation."}

    ICD10

    {"project":"ICD10","denotations":[{"id":"T1","span":{"begin":777,"end":793},"obj":"http://purl.bioontology.org/ontology/ICD10/C46"},{"id":"T2","span":{"begin":777,"end":793},"obj":"http://purl.bioontology.org/ontology/ICD10/C46.9"}],"text":"O-GlcNAc transferase inhibits KSHV propagation and modifies replication relevant viral proteins as detected by systematic O-GlcNAcylation analysis.\nO-GlcNAcylation is an inducible, highly dynamic and reversible post-translational modification, mediated by a unique enzyme named O-linked N-acetyl-d-glucosamine (O-GlcNAc) transferase (OGT). In response to nutrients, O-GlcNAc levels are differentially regulated on many cellular proteins involved in gene expression, translation, immune reactions, protein degradation, protein-protein interaction, apoptosis and signal transduction. In contrast to eukaryotic cells, little is known about the role of O-GlcNAcylation in the viral life cycle. Here, we show that the overexpression of the OGT reduces the replication efficiency of Kaposi's sarcoma-associated herpesvirus (KSHV) in a dose-dependent manner. In order to investigate the global impact of O-GlcNAcylation in the KSHV life cycle, we systematically analyzed the 85 annotated KSHV-encoded open reading frames for O-GlcNAc modification. For this purpose, an immunoprecipitation (IP) strategy with three different approaches was carried out and the O-GlcNAc signal of the identified proteins was properly controlled for specificity. Out of the 85 KSHV-encoded proteins, 18 proteins were found to be direct targets for O-GlcNAcylation. Selected proteins were further confirmed by mass spectrometry for O-GlcNAc modification. Correlation of the functional annotation and the O-GlcNAc status of KSHV proteins showed that the predominant targets were proteins involved in viral DNA synthesis and replication. These results indicate that O-GlcNAcylation plays a major role in the regulation of KSHV propagation."}

    GlycoBiology-FMA

    {"project":"GlycoBiology-FMA","denotations":[{"id":"_T1","span":{"begin":87,"end":95},"obj":"FMAID:67257"},{"id":"_T2","span":{"begin":87,"end":95},"obj":"FMAID:165447"},{"id":"_T3","span":{"begin":298,"end":309},"obj":"FMAID:196792"},{"id":"_T4","span":{"begin":298,"end":309},"obj":"FMAID:82797"},{"id":"_T5","span":{"begin":428,"end":436},"obj":"FMAID:67257"},{"id":"_T6","span":{"begin":428,"end":436},"obj":"FMAID:165447"},{"id":"_T7","span":{"begin":449,"end":453},"obj":"FMAID:198663"},{"id":"_T8","span":{"begin":497,"end":504},"obj":"FMAID:165447"},{"id":"_T9","span":{"begin":497,"end":504},"obj":"FMAID:67257"},{"id":"_T10","span":{"begin":497,"end":533},"obj":"FMAID:242150"},{"id":"_T11","span":{"begin":497,"end":533},"obj":"FMAID:67140"},{"id":"_T12","span":{"begin":497,"end":533},"obj":"FMAID:165433"},{"id":"_T13","span":{"begin":497,"end":533},"obj":"FMAID:165437"},{"id":"_T14","span":{"begin":497,"end":533},"obj":"FMAID:67132"},{"id":"_T15","span":{"begin":497,"end":533},"obj":"FMAID:242151"},{"id":"_T16","span":{"begin":518,"end":525},"obj":"FMAID:165447"},{"id":"_T17","span":{"begin":518,"end":525},"obj":"FMAID:67257"},{"id":"_T18","span":{"begin":518,"end":533},"obj":"FMAID:199792"},{"id":"_T19","span":{"begin":518,"end":533},"obj":"FMAID:85438"},{"id":"_T20","span":{"begin":518,"end":533},"obj":"FMAID:166112"},{"id":"_T21","span":{"begin":518,"end":533},"obj":"FMAID:165914"},{"id":"_T22","span":{"begin":518,"end":533},"obj":"FMAID:62925"},{"id":"_T23","span":{"begin":518,"end":533},"obj":"FMAID:167256"},{"id":"_T24","span":{"begin":518,"end":533},"obj":"FMAID:63169"},{"id":"_T25","span":{"begin":518,"end":533},"obj":"FMAID:167415"},{"id":"_T26","span":{"begin":518,"end":533},"obj":"FMAID:198030"},{"id":"_T27","span":{"begin":518,"end":533},"obj":"FMAID:62378"},{"id":"_T28","span":{"begin":518,"end":533},"obj":"FMAID:62290"},{"id":"_T29","span":{"begin":518,"end":533},"obj":"FMAID:90067"},{"id":"_T30","span":{"begin":518,"end":533},"obj":"FMAID:231312"},{"id":"_T31","span":{"begin":518,"end":533},"obj":"FMAID:231313"},{"id":"_T32","span":{"begin":518,"end":533},"obj":"FMAID:165438"},{"id":"_T33","span":{"begin":518,"end":533},"obj":"FMAID:165434"},{"id":"_T34","span":{"begin":518,"end":533},"obj":"FMAID:165476"},{"id":"_T35","span":{"begin":518,"end":533},"obj":"FMAID:165470"},{"id":"_T36","span":{"begin":518,"end":533},"obj":"FMAID:165475"},{"id":"_T37","span":{"begin":518,"end":533},"obj":"FMAID:231305"},{"id":"_T38","span":{"begin":518,"end":533},"obj":"FMAID:231304"},{"id":"_T39","span":{"begin":518,"end":533},"obj":"FMAID:174224"},{"id":"_T40","span":{"begin":518,"end":533},"obj":"FMAID:72158"},{"id":"_T41","span":{"begin":518,"end":533},"obj":"FMAID:67906"},{"id":"_T42","span":{"begin":518,"end":533},"obj":"FMAID:231303"},{"id":"_T43","span":{"begin":518,"end":533},"obj":"FMAID:67119"},{"id":"_T44","span":{"begin":518,"end":533},"obj":"FMAID:165430"},{"id":"_T45","span":{"begin":518,"end":533},"obj":"FMAID:165866"},{"id":"_T46","span":{"begin":518,"end":533},"obj":"FMAID:231302"},{"id":"_T47","span":{"begin":526,"end":533},"obj":"FMAID:67257"},{"id":"_T48","span":{"begin":526,"end":533},"obj":"FMAID:165447"},{"id":"_T49","span":{"begin":608,"end":613},"obj":"FMAID:169002"},{"id":"_T50","span":{"begin":608,"end":613},"obj":"FMAID:68646"},{"id":"_T51","span":{"begin":1186,"end":1194},"obj":"FMAID:67257"},{"id":"_T52","span":{"begin":1186,"end":1194},"obj":"FMAID:165447"},{"id":"_T53","span":{"begin":1263,"end":1271},"obj":"FMAID:67257"},{"id":"_T54","span":{"begin":1263,"end":1271},"obj":"FMAID:165447"},{"id":"_T55","span":{"begin":1263,"end":1284},"obj":"FMAID:198030"},{"id":"_T56","span":{"begin":1276,"end":1284},"obj":"FMAID:165447"},{"id":"_T57","span":{"begin":1276,"end":1284},"obj":"FMAID:67257"},{"id":"_T58","span":{"begin":1347,"end":1355},"obj":"FMAID:67257"},{"id":"_T59","span":{"begin":1347,"end":1355},"obj":"FMAID:165447"},{"id":"_T60","span":{"begin":1500,"end":1508},"obj":"FMAID:67257"},{"id":"_T61","span":{"begin":1500,"end":1508},"obj":"FMAID:165447"},{"id":"_T62","span":{"begin":1550,"end":1558},"obj":"FMAID:67257"},{"id":"_T63","span":{"begin":1550,"end":1558},"obj":"FMAID:165447"}],"namespaces":[{"prefix":"FMAID","uri":"http://purl.org/sig/ont/fma/fma"}],"text":"O-GlcNAc transferase inhibits KSHV propagation and modifies replication relevant viral proteins as detected by systematic O-GlcNAcylation analysis.\nO-GlcNAcylation is an inducible, highly dynamic and reversible post-translational modification, mediated by a unique enzyme named O-linked N-acetyl-d-glucosamine (O-GlcNAc) transferase (OGT). In response to nutrients, O-GlcNAc levels are differentially regulated on many cellular proteins involved in gene expression, translation, immune reactions, protein degradation, protein-protein interaction, apoptosis and signal transduction. In contrast to eukaryotic cells, little is known about the role of O-GlcNAcylation in the viral life cycle. Here, we show that the overexpression of the OGT reduces the replication efficiency of Kaposi's sarcoma-associated herpesvirus (KSHV) in a dose-dependent manner. In order to investigate the global impact of O-GlcNAcylation in the KSHV life cycle, we systematically analyzed the 85 annotated KSHV-encoded open reading frames for O-GlcNAc modification. For this purpose, an immunoprecipitation (IP) strategy with three different approaches was carried out and the O-GlcNAc signal of the identified proteins was properly controlled for specificity. Out of the 85 KSHV-encoded proteins, 18 proteins were found to be direct targets for O-GlcNAcylation. Selected proteins were further confirmed by mass spectrometry for O-GlcNAc modification. Correlation of the functional annotation and the O-GlcNAc status of KSHV proteins showed that the predominant targets were proteins involved in viral DNA synthesis and replication. These results indicate that O-GlcNAcylation plays a major role in the regulation of KSHV propagation."}

    uniprot-human

    {"project":"uniprot-human","denotations":[{"id":"T1","span":{"begin":9,"end":20},"obj":"http://www.uniprot.org/uniprot/Q99484"},{"id":"T2","span":{"begin":321,"end":332},"obj":"http://www.uniprot.org/uniprot/Q99484"},{"id":"T3","span":{"begin":334,"end":337},"obj":"http://www.uniprot.org/uniprot/O15294"},{"id":"T4","span":{"begin":735,"end":738},"obj":"http://www.uniprot.org/uniprot/O15294"}],"text":"O-GlcNAc transferase inhibits KSHV propagation and modifies replication relevant viral proteins as detected by systematic O-GlcNAcylation analysis.\nO-GlcNAcylation is an inducible, highly dynamic and reversible post-translational modification, mediated by a unique enzyme named O-linked N-acetyl-d-glucosamine (O-GlcNAc) transferase (OGT). In response to nutrients, O-GlcNAc levels are differentially regulated on many cellular proteins involved in gene expression, translation, immune reactions, protein degradation, protein-protein interaction, apoptosis and signal transduction. In contrast to eukaryotic cells, little is known about the role of O-GlcNAcylation in the viral life cycle. Here, we show that the overexpression of the OGT reduces the replication efficiency of Kaposi's sarcoma-associated herpesvirus (KSHV) in a dose-dependent manner. In order to investigate the global impact of O-GlcNAcylation in the KSHV life cycle, we systematically analyzed the 85 annotated KSHV-encoded open reading frames for O-GlcNAc modification. For this purpose, an immunoprecipitation (IP) strategy with three different approaches was carried out and the O-GlcNAc signal of the identified proteins was properly controlled for specificity. Out of the 85 KSHV-encoded proteins, 18 proteins were found to be direct targets for O-GlcNAcylation. Selected proteins were further confirmed by mass spectrometry for O-GlcNAc modification. Correlation of the functional annotation and the O-GlcNAc status of KSHV proteins showed that the predominant targets were proteins involved in viral DNA synthesis and replication. These results indicate that O-GlcNAcylation plays a major role in the regulation of KSHV propagation."}

    uniprot-mouse

    {"project":"uniprot-mouse","denotations":[{"id":"T1","span":{"begin":9,"end":20},"obj":"http://www.uniprot.org/uniprot/P38649"},{"id":"T2","span":{"begin":321,"end":332},"obj":"http://www.uniprot.org/uniprot/P38649"},{"id":"T3","span":{"begin":334,"end":337},"obj":"http://www.uniprot.org/uniprot/Q8CGY8"},{"id":"T4","span":{"begin":735,"end":738},"obj":"http://www.uniprot.org/uniprot/Q8CGY8"}],"text":"O-GlcNAc transferase inhibits KSHV propagation and modifies replication relevant viral proteins as detected by systematic O-GlcNAcylation analysis.\nO-GlcNAcylation is an inducible, highly dynamic and reversible post-translational modification, mediated by a unique enzyme named O-linked N-acetyl-d-glucosamine (O-GlcNAc) transferase (OGT). In response to nutrients, O-GlcNAc levels are differentially regulated on many cellular proteins involved in gene expression, translation, immune reactions, protein degradation, protein-protein interaction, apoptosis and signal transduction. In contrast to eukaryotic cells, little is known about the role of O-GlcNAcylation in the viral life cycle. Here, we show that the overexpression of the OGT reduces the replication efficiency of Kaposi's sarcoma-associated herpesvirus (KSHV) in a dose-dependent manner. In order to investigate the global impact of O-GlcNAcylation in the KSHV life cycle, we systematically analyzed the 85 annotated KSHV-encoded open reading frames for O-GlcNAc modification. For this purpose, an immunoprecipitation (IP) strategy with three different approaches was carried out and the O-GlcNAc signal of the identified proteins was properly controlled for specificity. Out of the 85 KSHV-encoded proteins, 18 proteins were found to be direct targets for O-GlcNAcylation. Selected proteins were further confirmed by mass spectrometry for O-GlcNAc modification. Correlation of the functional annotation and the O-GlcNAc status of KSHV proteins showed that the predominant targets were proteins involved in viral DNA synthesis and replication. These results indicate that O-GlcNAcylation plays a major role in the regulation of KSHV propagation."}

    GlycoBiology-NCBITAXON

    {"project":"GlycoBiology-NCBITAXON","denotations":[{"id":"T1","span":{"begin":414,"end":418},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/9973"},{"id":"T2","span":{"begin":518,"end":533},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/66543"},{"id":"T3","span":{"begin":518,"end":533},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/415014"},{"id":"T4","span":{"begin":518,"end":533},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/66322"},{"id":"T5","span":{"begin":597,"end":607},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/2759"},{"id":"T6","span":{"begin":608,"end":613},"obj":"http://purl.bioontology.org/ontology/STY/T025"},{"id":"T7","span":{"begin":786,"end":793},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/47206"},{"id":"T8","span":{"begin":1083,"end":1085},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/55979"}],"text":"O-GlcNAc transferase inhibits KSHV propagation and modifies replication relevant viral proteins as detected by systematic O-GlcNAcylation analysis.\nO-GlcNAcylation is an inducible, highly dynamic and reversible post-translational modification, mediated by a unique enzyme named O-linked N-acetyl-d-glucosamine (O-GlcNAc) transferase (OGT). In response to nutrients, O-GlcNAc levels are differentially regulated on many cellular proteins involved in gene expression, translation, immune reactions, protein degradation, protein-protein interaction, apoptosis and signal transduction. In contrast to eukaryotic cells, little is known about the role of O-GlcNAcylation in the viral life cycle. Here, we show that the overexpression of the OGT reduces the replication efficiency of Kaposi's sarcoma-associated herpesvirus (KSHV) in a dose-dependent manner. In order to investigate the global impact of O-GlcNAcylation in the KSHV life cycle, we systematically analyzed the 85 annotated KSHV-encoded open reading frames for O-GlcNAc modification. For this purpose, an immunoprecipitation (IP) strategy with three different approaches was carried out and the O-GlcNAc signal of the identified proteins was properly controlled for specificity. Out of the 85 KSHV-encoded proteins, 18 proteins were found to be direct targets for O-GlcNAcylation. Selected proteins were further confirmed by mass spectrometry for O-GlcNAc modification. Correlation of the functional annotation and the O-GlcNAc status of KSHV proteins showed that the predominant targets were proteins involved in viral DNA synthesis and replication. These results indicate that O-GlcNAcylation plays a major role in the regulation of KSHV propagation."}

    GO-BP

    {"project":"GO-BP","denotations":[{"id":"T1","span":{"begin":211,"end":242},"obj":"http://purl.obolibrary.org/obo/GO_1901875"},{"id":"T2","span":{"begin":211,"end":242},"obj":"http://purl.obolibrary.org/obo/GO_1901873"},{"id":"T3","span":{"begin":211,"end":242},"obj":"http://purl.obolibrary.org/obo/GO_1901874"},{"id":"T4","span":{"begin":211,"end":242},"obj":"http://purl.obolibrary.org/obo/GO_0043687"},{"id":"T5","span":{"begin":216,"end":229},"obj":"http://purl.obolibrary.org/obo/GO_0006412"},{"id":"T6","span":{"begin":466,"end":477},"obj":"http://purl.obolibrary.org/obo/GO_0006412"},{"id":"T7","span":{"begin":311,"end":332},"obj":"http://purl.obolibrary.org/obo/GO_0097363"},{"id":"T8","span":{"begin":334,"end":337},"obj":"http://purl.obolibrary.org/obo/GO_0047487"},{"id":"T9","span":{"begin":735,"end":738},"obj":"http://purl.obolibrary.org/obo/GO_0047487"},{"id":"T10","span":{"begin":343,"end":364},"obj":"http://purl.obolibrary.org/obo/GO_0007584"},{"id":"T11","span":{"begin":401,"end":410},"obj":"http://purl.obolibrary.org/obo/GO_0065007"},{"id":"T12","span":{"begin":1678,"end":1688},"obj":"http://purl.obolibrary.org/obo/GO_0065007"},{"id":"T13","span":{"begin":419,"end":427},"obj":"http://purl.obolibrary.org/obo/GO_0007349"},{"id":"T14","span":{"begin":449,"end":464},"obj":"http://purl.obolibrary.org/obo/GO_0010467"},{"id":"T15","span":{"begin":505,"end":525},"obj":"http://purl.obolibrary.org/obo/GO_0030163"},{"id":"T16","span":{"begin":505,"end":516},"obj":"http://purl.obolibrary.org/obo/GO_0009056"},{"id":"T17","span":{"begin":547,"end":556},"obj":"http://purl.obolibrary.org/obo/GO_0006915"},{"id":"T18","span":{"begin":547,"end":556},"obj":"http://purl.obolibrary.org/obo/GO_0097194"},{"id":"T19","span":{"begin":547,"end":567},"obj":"http://purl.obolibrary.org/obo/GO_0006915"},{"id":"T20","span":{"begin":561,"end":567},"obj":"http://purl.obolibrary.org/obo/GO_0023052"},{"id":"T21","span":{"begin":1161,"end":1167},"obj":"http://purl.obolibrary.org/obo/GO_0023052"},{"id":"T22","span":{"begin":561,"end":580},"obj":"http://purl.obolibrary.org/obo/GO_0007165"},{"id":"T23","span":{"begin":568,"end":580},"obj":"http://purl.obolibrary.org/obo/GO_0009293"},{"id":"T24","span":{"begin":672,"end":688},"obj":"http://purl.obolibrary.org/obo/GO_0048524"},{"id":"T25","span":{"begin":672,"end":688},"obj":"http://purl.obolibrary.org/obo/GO_1903902"},{"id":"T26","span":{"begin":672,"end":688},"obj":"http://purl.obolibrary.org/obo/GO_0019058"},{"id":"T27","span":{"begin":672,"end":688},"obj":"http://purl.obolibrary.org/obo/GO_0044659"},{"id":"T28","span":{"begin":672,"end":688},"obj":"http://purl.obolibrary.org/obo/GO_0048525"},{"id":"T29","span":{"begin":672,"end":688},"obj":"http://purl.obolibrary.org/obo/GO_1903901"},{"id":"T30","span":{"begin":672,"end":688},"obj":"http://purl.obolibrary.org/obo/GO_0050792"},{"id":"T31","span":{"begin":672,"end":688},"obj":"http://purl.obolibrary.org/obo/GO_1903900"},{"id":"T32","span":{"begin":1577,"end":1590},"obj":"http://purl.obolibrary.org/obo/GO_0071897"},{"id":"T33","span":{"begin":1581,"end":1590},"obj":"http://purl.obolibrary.org/obo/GO_0009058"}],"text":"O-GlcNAc transferase inhibits KSHV propagation and modifies replication relevant viral proteins as detected by systematic O-GlcNAcylation analysis.\nO-GlcNAcylation is an inducible, highly dynamic and reversible post-translational modification, mediated by a unique enzyme named O-linked N-acetyl-d-glucosamine (O-GlcNAc) transferase (OGT). In response to nutrients, O-GlcNAc levels are differentially regulated on many cellular proteins involved in gene expression, translation, immune reactions, protein degradation, protein-protein interaction, apoptosis and signal transduction. In contrast to eukaryotic cells, little is known about the role of O-GlcNAcylation in the viral life cycle. Here, we show that the overexpression of the OGT reduces the replication efficiency of Kaposi's sarcoma-associated herpesvirus (KSHV) in a dose-dependent manner. In order to investigate the global impact of O-GlcNAcylation in the KSHV life cycle, we systematically analyzed the 85 annotated KSHV-encoded open reading frames for O-GlcNAc modification. For this purpose, an immunoprecipitation (IP) strategy with three different approaches was carried out and the O-GlcNAc signal of the identified proteins was properly controlled for specificity. Out of the 85 KSHV-encoded proteins, 18 proteins were found to be direct targets for O-GlcNAcylation. Selected proteins were further confirmed by mass spectrometry for O-GlcNAc modification. Correlation of the functional annotation and the O-GlcNAc status of KSHV proteins showed that the predominant targets were proteins involved in viral DNA synthesis and replication. These results indicate that O-GlcNAcylation plays a major role in the regulation of KSHV propagation."}

    GO-CC

    {"project":"GO-CC","denotations":[{"id":"T1","span":{"begin":311,"end":332},"obj":"http://purl.obolibrary.org/obo/GO_0017122"},{"id":"T2","span":{"begin":608,"end":613},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"O-GlcNAc transferase inhibits KSHV propagation and modifies replication relevant viral proteins as detected by systematic O-GlcNAcylation analysis.\nO-GlcNAcylation is an inducible, highly dynamic and reversible post-translational modification, mediated by a unique enzyme named O-linked N-acetyl-d-glucosamine (O-GlcNAc) transferase (OGT). In response to nutrients, O-GlcNAc levels are differentially regulated on many cellular proteins involved in gene expression, translation, immune reactions, protein degradation, protein-protein interaction, apoptosis and signal transduction. In contrast to eukaryotic cells, little is known about the role of O-GlcNAcylation in the viral life cycle. Here, we show that the overexpression of the OGT reduces the replication efficiency of Kaposi's sarcoma-associated herpesvirus (KSHV) in a dose-dependent manner. In order to investigate the global impact of O-GlcNAcylation in the KSHV life cycle, we systematically analyzed the 85 annotated KSHV-encoded open reading frames for O-GlcNAc modification. For this purpose, an immunoprecipitation (IP) strategy with three different approaches was carried out and the O-GlcNAc signal of the identified proteins was properly controlled for specificity. Out of the 85 KSHV-encoded proteins, 18 proteins were found to be direct targets for O-GlcNAcylation. Selected proteins were further confirmed by mass spectrometry for O-GlcNAc modification. Correlation of the functional annotation and the O-GlcNAc status of KSHV proteins showed that the predominant targets were proteins involved in viral DNA synthesis and replication. These results indicate that O-GlcNAcylation plays a major role in the regulation of KSHV propagation."}

    EDAM-topics

    {"project":"EDAM-topics","denotations":[{"id":"T1","span":{"begin":87,"end":95},"obj":"http://edamontology.org/topic_0078"},{"id":"T2","span":{"begin":211,"end":242},"obj":"http://edamontology.org/topic_3541"},{"id":"T3","span":{"begin":211,"end":242},"obj":"http://edamontology.org/topic_0601"},{"id":"T4","span":{"begin":216,"end":229},"obj":"http://edamontology.org/topic_0108"},{"id":"T5","span":{"begin":428,"end":436},"obj":"http://edamontology.org/topic_0078"},{"id":"T6","span":{"begin":449,"end":464},"obj":"http://edamontology.org/topic_0203"},{"id":"T7","span":{"begin":466,"end":477},"obj":"http://edamontology.org/topic_0108"},{"id":"T8","span":{"begin":497,"end":504},"obj":"http://edamontology.org/topic_0078"},{"id":"T9","span":{"begin":518,"end":525},"obj":"http://edamontology.org/topic_0078"},{"id":"T10","span":{"begin":518,"end":545},"obj":"http://edamontology.org/topic_0147"},{"id":"T11","span":{"begin":518,"end":545},"obj":"http://edamontology.org/topic_0078"},{"id":"T12","span":{"begin":518,"end":545},"obj":"http://edamontology.org/topic_0149"},{"id":"T13","span":{"begin":518,"end":545},"obj":"http://edamontology.org/topic_3557"},{"id":"T14","span":{"begin":518,"end":545},"obj":"http://edamontology.org/topic_0128"},{"id":"T15","span":{"begin":518,"end":545},"obj":"http://edamontology.org/topic_3525"},{"id":"T16","span":{"begin":518,"end":545},"obj":"http://edamontology.org/topic_3526"},{"id":"T17","span":{"begin":518,"end":545},"obj":"http://edamontology.org/topic_3044"},{"id":"T18","span":{"begin":526,"end":533},"obj":"http://edamontology.org/topic_0078"},{"id":"T19","span":{"begin":526,"end":545},"obj":"http://edamontology.org/topic_3515"},{"id":"T20","span":{"begin":526,"end":545},"obj":"http://edamontology.org/topic_3514"},{"id":"T21","span":{"begin":526,"end":545},"obj":"http://edamontology.org/topic_0148"},{"id":"T22","span":{"begin":526,"end":545},"obj":"http://edamontology.org/topic_0128"},{"id":"T23","span":{"begin":526,"end":545},"obj":"http://edamontology.org/topic_0144"},{"id":"T24","span":{"begin":526,"end":545},"obj":"http://edamontology.org/topic_0130"},{"id":"T25","span":{"begin":534,"end":545},"obj":"http://edamontology.org/topic_0602"},{"id":"T26","span":{"begin":597,"end":607},"obj":"http://edamontology.org/topic_2818"},{"id":"T27","span":{"begin":1062,"end":1081},"obj":"http://edamontology.org/topic_3557"},{"id":"T28","span":{"begin":1186,"end":1194},"obj":"http://edamontology.org/topic_0078"},{"id":"T29","span":{"begin":1263,"end":1271},"obj":"http://edamontology.org/topic_0078"},{"id":"T30","span":{"begin":1263,"end":1284},"obj":"http://edamontology.org/topic_0736"},{"id":"T31","span":{"begin":1263,"end":1284},"obj":"http://edamontology.org/topic_3539"},{"id":"T32","span":{"begin":1276,"end":1284},"obj":"http://edamontology.org/topic_0078"},{"id":"T33","span":{"begin":1309,"end":1316},"obj":"http://edamontology.org/topic_0154"},{"id":"T34","span":{"begin":1347,"end":1355},"obj":"http://edamontology.org/topic_0078"},{"id":"T35","span":{"begin":1382,"end":1399},"obj":"http://edamontology.org/topic_0134"},{"id":"T36","span":{"begin":1382,"end":1399},"obj":"http://edamontology.org/topic_3520"},{"id":"T37","span":{"begin":1500,"end":1508},"obj":"http://edamontology.org/topic_0078"},{"id":"T38","span":{"begin":1537,"end":1544},"obj":"http://edamontology.org/topic_0154"},{"id":"T39","span":{"begin":1550,"end":1558},"obj":"http://edamontology.org/topic_0078"}],"text":"O-GlcNAc transferase inhibits KSHV propagation and modifies replication relevant viral proteins as detected by systematic O-GlcNAcylation analysis.\nO-GlcNAcylation is an inducible, highly dynamic and reversible post-translational modification, mediated by a unique enzyme named O-linked N-acetyl-d-glucosamine (O-GlcNAc) transferase (OGT). In response to nutrients, O-GlcNAc levels are differentially regulated on many cellular proteins involved in gene expression, translation, immune reactions, protein degradation, protein-protein interaction, apoptosis and signal transduction. In contrast to eukaryotic cells, little is known about the role of O-GlcNAcylation in the viral life cycle. Here, we show that the overexpression of the OGT reduces the replication efficiency of Kaposi's sarcoma-associated herpesvirus (KSHV) in a dose-dependent manner. In order to investigate the global impact of O-GlcNAcylation in the KSHV life cycle, we systematically analyzed the 85 annotated KSHV-encoded open reading frames for O-GlcNAc modification. For this purpose, an immunoprecipitation (IP) strategy with three different approaches was carried out and the O-GlcNAc signal of the identified proteins was properly controlled for specificity. Out of the 85 KSHV-encoded proteins, 18 proteins were found to be direct targets for O-GlcNAcylation. Selected proteins were further confirmed by mass spectrometry for O-GlcNAc modification. Correlation of the functional annotation and the O-GlcNAc status of KSHV proteins showed that the predominant targets were proteins involved in viral DNA synthesis and replication. These results indicate that O-GlcNAcylation plays a major role in the regulation of KSHV propagation."}

    EDAM-DFO

    {"project":"EDAM-DFO","denotations":[{"id":"T1","span":{"begin":87,"end":95},"obj":"http://edamontology.org/format_1208"},{"id":"T2","span":{"begin":87,"end":95},"obj":"http://edamontology.org/data_1467"},{"id":"T3","span":{"begin":87,"end":107},"obj":"http://edamontology.org/operation_3087"},{"id":"T4","span":{"begin":99,"end":107},"obj":"http://edamontology.org/operation_2423"},{"id":"T5","span":{"begin":138,"end":146},"obj":"http://edamontology.org/operation_2945"},{"id":"T6","span":{"begin":265,"end":277},"obj":"http://edamontology.org/data_1012"},{"id":"T7","span":{"begin":272,"end":277},"obj":"http://edamontology.org/data_2099"},{"id":"T8","span":{"begin":428,"end":436},"obj":"http://edamontology.org/data_1467"},{"id":"T9","span":{"begin":428,"end":436},"obj":"http://edamontology.org/format_1208"},{"id":"T10","span":{"begin":497,"end":504},"obj":"http://edamontology.org/data_1467"},{"id":"T11","span":{"begin":497,"end":504},"obj":"http://edamontology.org/format_1208"},{"id":"T12","span":{"begin":518,"end":525},"obj":"http://edamontology.org/data_1467"},{"id":"T13","span":{"begin":518,"end":525},"obj":"http://edamontology.org/format_1208"},{"id":"T14","span":{"begin":518,"end":545},"obj":"http://edamontology.org/data_1566"},{"id":"T15","span":{"begin":518,"end":545},"obj":"http://edamontology.org/data_2402"},{"id":"T16","span":{"begin":518,"end":545},"obj":"http://edamontology.org/data_0906"},{"id":"T17","span":{"begin":518,"end":545},"obj":"http://edamontology.org/data_1565"},{"id":"T18","span":{"begin":518,"end":545},"obj":"http://edamontology.org/operation_2949"},{"id":"T19","span":{"begin":518,"end":545},"obj":"http://edamontology.org/operation_2405"},{"id":"T20","span":{"begin":518,"end":545},"obj":"http://edamontology.org/data_0905"},{"id":"T21","span":{"begin":518,"end":545},"obj":"http://edamontology.org/data_1663"},{"id":"T22","span":{"begin":518,"end":545},"obj":"http://edamontology.org/operation_3094"},{"id":"T23","span":{"begin":518,"end":545},"obj":"http://edamontology.org/operation_2445"},{"id":"T24","span":{"begin":518,"end":545},"obj":"http://edamontology.org/data_1550"},{"id":"T25","span":{"begin":518,"end":545},"obj":"http://edamontology.org/operation_2464"},{"id":"T26","span":{"begin":526,"end":533},"obj":"http://edamontology.org/format_1208"},{"id":"T27","span":{"begin":526,"end":533},"obj":"http://edamontology.org/data_1467"},{"id":"T28","span":{"begin":526,"end":545},"obj":"http://edamontology.org/data_0906"},{"id":"T29","span":{"begin":526,"end":545},"obj":"http://edamontology.org/format_2054"},{"id":"T30","span":{"begin":526,"end":545},"obj":"http://edamontology.org/data_1074"},{"id":"T31","span":{"begin":526,"end":545},"obj":"http://edamontology.org/data_2378"},{"id":"T32","span":{"begin":526,"end":545},"obj":"http://edamontology.org/operation_2492"},{"id":"T33","span":{"begin":526,"end":545},"obj":"http://edamontology.org/data_1550"},{"id":"T34","span":{"begin":971,"end":980},"obj":"http://edamontology.org/operation_0226"},{"id":"T35","span":{"begin":971,"end":980},"obj":"http://edamontology.org/data_2018"},{"id":"T36","span":{"begin":1175,"end":1185},"obj":"http://edamontology.org/data_0842"},{"id":"T37","span":{"begin":1175,"end":1185},"obj":"http://edamontology.org/data_2611"},{"id":"T38","span":{"begin":1186,"end":1194},"obj":"http://edamontology.org/data_1467"},{"id":"T39","span":{"begin":1186,"end":1194},"obj":"http://edamontology.org/format_1208"},{"id":"T40","span":{"begin":1263,"end":1271},"obj":"http://edamontology.org/format_1208"},{"id":"T41","span":{"begin":1263,"end":1271},"obj":"http://edamontology.org/data_1467"},{"id":"T42","span":{"begin":1263,"end":1284},"obj":"http://edamontology.org/format_1219"},{"id":"T43","span":{"begin":1263,"end":1284},"obj":"http://edamontology.org/data_1468"},{"id":"T44","span":{"begin":1276,"end":1284},"obj":"http://edamontology.org/data_1467"},{"id":"T45","span":{"begin":1276,"end":1284},"obj":"http://edamontology.org/format_1208"},{"id":"T46","span":{"begin":1347,"end":1355},"obj":"http://edamontology.org/format_1208"},{"id":"T47","span":{"begin":1347,"end":1355},"obj":"http://edamontology.org/data_1467"},{"id":"T48","span":{"begin":1382,"end":1399},"obj":"http://edamontology.org/data_3147"},{"id":"T49","span":{"begin":1382,"end":1399},"obj":"http://edamontology.org/data_2536"},{"id":"T50","span":{"begin":1427,"end":1438},"obj":"http://edamontology.org/operation_3465"},{"id":"T51","span":{"begin":1446,"end":1467},"obj":"http://edamontology.org/operation_3672"},{"id":"T52","span":{"begin":1457,"end":1467},"obj":"http://edamontology.org/data_2018"},{"id":"T53","span":{"begin":1457,"end":1467},"obj":"http://edamontology.org/operation_0226"},{"id":"T54","span":{"begin":1500,"end":1508},"obj":"http://edamontology.org/data_1467"},{"id":"T55","span":{"begin":1500,"end":1508},"obj":"http://edamontology.org/format_1208"},{"id":"T56","span":{"begin":1550,"end":1558},"obj":"http://edamontology.org/data_1467"},{"id":"T57","span":{"begin":1550,"end":1558},"obj":"http://edamontology.org/format_1208"}],"text":"O-GlcNAc transferase inhibits KSHV propagation and modifies replication relevant viral proteins as detected by systematic O-GlcNAcylation analysis.\nO-GlcNAcylation is an inducible, highly dynamic and reversible post-translational modification, mediated by a unique enzyme named O-linked N-acetyl-d-glucosamine (O-GlcNAc) transferase (OGT). In response to nutrients, O-GlcNAc levels are differentially regulated on many cellular proteins involved in gene expression, translation, immune reactions, protein degradation, protein-protein interaction, apoptosis and signal transduction. In contrast to eukaryotic cells, little is known about the role of O-GlcNAcylation in the viral life cycle. Here, we show that the overexpression of the OGT reduces the replication efficiency of Kaposi's sarcoma-associated herpesvirus (KSHV) in a dose-dependent manner. In order to investigate the global impact of O-GlcNAcylation in the KSHV life cycle, we systematically analyzed the 85 annotated KSHV-encoded open reading frames for O-GlcNAc modification. For this purpose, an immunoprecipitation (IP) strategy with three different approaches was carried out and the O-GlcNAc signal of the identified proteins was properly controlled for specificity. Out of the 85 KSHV-encoded proteins, 18 proteins were found to be direct targets for O-GlcNAcylation. Selected proteins were further confirmed by mass spectrometry for O-GlcNAc modification. Correlation of the functional annotation and the O-GlcNAc status of KSHV proteins showed that the predominant targets were proteins involved in viral DNA synthesis and replication. These results indicate that O-GlcNAcylation plays a major role in the regulation of KSHV propagation."}

    Allie

    {"project":"Allie","denotations":[{"id":"SS1_23580777_1_0","span":{"begin":278,"end":309},"obj":"expanded"},{"id":"SS2_23580777_1_0","span":{"begin":311,"end":319},"obj":"abbr"},{"id":"SS1_23580777_4_0","span":{"begin":777,"end":816},"obj":"expanded"},{"id":"SS2_23580777_4_0","span":{"begin":818,"end":822},"obj":"abbr"},{"id":"SS1_23580777_6_0","span":{"begin":1062,"end":1081},"obj":"expanded"},{"id":"SS2_23580777_6_0","span":{"begin":1083,"end":1085},"obj":"abbr"}],"relations":[{"id":"AE1_23580777_1_0","pred":"abbreviatedTo","subj":"SS1_23580777_1_0","obj":"SS2_23580777_1_0"},{"id":"AE1_23580777_4_0","pred":"abbreviatedTo","subj":"SS1_23580777_4_0","obj":"SS2_23580777_4_0"},{"id":"AE1_23580777_6_0","pred":"abbreviatedTo","subj":"SS1_23580777_6_0","obj":"SS2_23580777_6_0"}],"text":"O-GlcNAc transferase inhibits KSHV propagation and modifies replication relevant viral proteins as detected by systematic O-GlcNAcylation analysis.\nO-GlcNAcylation is an inducible, highly dynamic and reversible post-translational modification, mediated by a unique enzyme named O-linked N-acetyl-d-glucosamine (O-GlcNAc) transferase (OGT). In response to nutrients, O-GlcNAc levels are differentially regulated on many cellular proteins involved in gene expression, translation, immune reactions, protein degradation, protein-protein interaction, apoptosis and signal transduction. In contrast to eukaryotic cells, little is known about the role of O-GlcNAcylation in the viral life cycle. Here, we show that the overexpression of the OGT reduces the replication efficiency of Kaposi's sarcoma-associated herpesvirus (KSHV) in a dose-dependent manner. In order to investigate the global impact of O-GlcNAcylation in the KSHV life cycle, we systematically analyzed the 85 annotated KSHV-encoded open reading frames for O-GlcNAc modification. For this purpose, an immunoprecipitation (IP) strategy with three different approaches was carried out and the O-GlcNAc signal of the identified proteins was properly controlled for specificity. Out of the 85 KSHV-encoded proteins, 18 proteins were found to be direct targets for O-GlcNAcylation. Selected proteins were further confirmed by mass spectrometry for O-GlcNAc modification. Correlation of the functional annotation and the O-GlcNAc status of KSHV proteins showed that the predominant targets were proteins involved in viral DNA synthesis and replication. These results indicate that O-GlcNAcylation plays a major role in the regulation of KSHV propagation."}

    PubmedHPO

    {"project":"PubmedHPO","denotations":[{"id":"T1","span":{"begin":777,"end":793},"obj":"HP_0100726"},{"id":"T2","span":{"begin":786,"end":793},"obj":"HP_0100242"}],"text":"O-GlcNAc transferase inhibits KSHV propagation and modifies replication relevant viral proteins as detected by systematic O-GlcNAcylation analysis.\nO-GlcNAcylation is an inducible, highly dynamic and reversible post-translational modification, mediated by a unique enzyme named O-linked N-acetyl-d-glucosamine (O-GlcNAc) transferase (OGT). In response to nutrients, O-GlcNAc levels are differentially regulated on many cellular proteins involved in gene expression, translation, immune reactions, protein degradation, protein-protein interaction, apoptosis and signal transduction. In contrast to eukaryotic cells, little is known about the role of O-GlcNAcylation in the viral life cycle. Here, we show that the overexpression of the OGT reduces the replication efficiency of Kaposi's sarcoma-associated herpesvirus (KSHV) in a dose-dependent manner. In order to investigate the global impact of O-GlcNAcylation in the KSHV life cycle, we systematically analyzed the 85 annotated KSHV-encoded open reading frames for O-GlcNAc modification. For this purpose, an immunoprecipitation (IP) strategy with three different approaches was carried out and the O-GlcNAc signal of the identified proteins was properly controlled for specificity. Out of the 85 KSHV-encoded proteins, 18 proteins were found to be direct targets for O-GlcNAcylation. Selected proteins were further confirmed by mass spectrometry for O-GlcNAc modification. Correlation of the functional annotation and the O-GlcNAc status of KSHV proteins showed that the predominant targets were proteins involved in viral DNA synthesis and replication. These results indicate that O-GlcNAcylation plays a major role in the regulation of KSHV propagation."}

    NGLY1-deficiency

    {"project":"NGLY1-deficiency","denotations":[{"id":"PD-NGLY1-deficiency-B_T1","span":{"begin":2,"end":8},"obj":"chem:24139"},{"id":"PD-NGLY1-deficiency-B_T2","span":{"begin":313,"end":319},"obj":"chem:24139"},{"id":"PD-NGLY1-deficiency-B_T3","span":{"begin":368,"end":374},"obj":"chem:24139"},{"id":"PD-NGLY1-deficiency-B_T4","span":{"begin":1020,"end":1026},"obj":"chem:24139"},{"id":"PD-NGLY1-deficiency-B_T5","span":{"begin":1154,"end":1160},"obj":"chem:24139"},{"id":"PD-NGLY1-deficiency-B_T6","span":{"begin":1406,"end":1412},"obj":"chem:24139"},{"id":"PD-NGLY1-deficiency-B_T7","span":{"begin":1478,"end":1484},"obj":"chem:24139"}],"namespaces":[{"prefix":"hgnc","uri":"https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:"},{"prefix":"omim","uri":"https://www.omim.org/entry/"},{"prefix":"chem","uri":"https://pubchem.ncbi.nlm.nih.gov/compound/"}],"text":"O-GlcNAc transferase inhibits KSHV propagation and modifies replication relevant viral proteins as detected by systematic O-GlcNAcylation analysis.\nO-GlcNAcylation is an inducible, highly dynamic and reversible post-translational modification, mediated by a unique enzyme named O-linked N-acetyl-d-glucosamine (O-GlcNAc) transferase (OGT). In response to nutrients, O-GlcNAc levels are differentially regulated on many cellular proteins involved in gene expression, translation, immune reactions, protein degradation, protein-protein interaction, apoptosis and signal transduction. In contrast to eukaryotic cells, little is known about the role of O-GlcNAcylation in the viral life cycle. Here, we show that the overexpression of the OGT reduces the replication efficiency of Kaposi's sarcoma-associated herpesvirus (KSHV) in a dose-dependent manner. In order to investigate the global impact of O-GlcNAcylation in the KSHV life cycle, we systematically analyzed the 85 annotated KSHV-encoded open reading frames for O-GlcNAc modification. For this purpose, an immunoprecipitation (IP) strategy with three different approaches was carried out and the O-GlcNAc signal of the identified proteins was properly controlled for specificity. Out of the 85 KSHV-encoded proteins, 18 proteins were found to be direct targets for O-GlcNAcylation. Selected proteins were further confirmed by mass spectrometry for O-GlcNAc modification. Correlation of the functional annotation and the O-GlcNAc status of KSHV proteins showed that the predominant targets were proteins involved in viral DNA synthesis and replication. These results indicate that O-GlcNAcylation plays a major role in the regulation of KSHV propagation."}

    GlycoBiology-Epitope

    {"project":"GlycoBiology-Epitope","denotations":[{"id":"PD-GlycoEpitope-B_T1","span":{"begin":0,"end":8},"obj":"http://www.glycoepitope.jp/epitopes/EP0004"},{"id":"PD-GlycoEpitope-B_T2","span":{"begin":311,"end":319},"obj":"http://www.glycoepitope.jp/epitopes/EP0004"},{"id":"PD-GlycoEpitope-B_T3","span":{"begin":366,"end":374},"obj":"http://www.glycoepitope.jp/epitopes/EP0004"},{"id":"PD-GlycoEpitope-B_T4","span":{"begin":1018,"end":1026},"obj":"http://www.glycoepitope.jp/epitopes/EP0004"},{"id":"PD-GlycoEpitope-B_T5","span":{"begin":1152,"end":1160},"obj":"http://www.glycoepitope.jp/epitopes/EP0004"},{"id":"PD-GlycoEpitope-B_T6","span":{"begin":1404,"end":1412},"obj":"http://www.glycoepitope.jp/epitopes/EP0004"},{"id":"PD-GlycoEpitope-B_T7","span":{"begin":1476,"end":1484},"obj":"http://www.glycoepitope.jp/epitopes/EP0004"}],"text":"O-GlcNAc transferase inhibits KSHV propagation and modifies replication relevant viral proteins as detected by systematic O-GlcNAcylation analysis.\nO-GlcNAcylation is an inducible, highly dynamic and reversible post-translational modification, mediated by a unique enzyme named O-linked N-acetyl-d-glucosamine (O-GlcNAc) transferase (OGT). In response to nutrients, O-GlcNAc levels are differentially regulated on many cellular proteins involved in gene expression, translation, immune reactions, protein degradation, protein-protein interaction, apoptosis and signal transduction. In contrast to eukaryotic cells, little is known about the role of O-GlcNAcylation in the viral life cycle. Here, we show that the overexpression of the OGT reduces the replication efficiency of Kaposi's sarcoma-associated herpesvirus (KSHV) in a dose-dependent manner. In order to investigate the global impact of O-GlcNAcylation in the KSHV life cycle, we systematically analyzed the 85 annotated KSHV-encoded open reading frames for O-GlcNAc modification. For this purpose, an immunoprecipitation (IP) strategy with three different approaches was carried out and the O-GlcNAc signal of the identified proteins was properly controlled for specificity. Out of the 85 KSHV-encoded proteins, 18 proteins were found to be direct targets for O-GlcNAcylation. Selected proteins were further confirmed by mass spectrometry for O-GlcNAc modification. Correlation of the functional annotation and the O-GlcNAc status of KSHV proteins showed that the predominant targets were proteins involved in viral DNA synthesis and replication. These results indicate that O-GlcNAcylation plays a major role in the regulation of KSHV propagation."}

    GlyTouCan-IUPAC

    {"project":"GlyTouCan-IUPAC","denotations":[{"id":"GlycanIUPAC_T1","span":{"begin":2,"end":8},"obj":"\"http://rdf.glycoinfo.org/glycan/G26693XF\""},{"id":"GlycanIUPAC_T2","span":{"begin":313,"end":319},"obj":"\"http://rdf.glycoinfo.org/glycan/G26693XF\""},{"id":"GlycanIUPAC_T3","span":{"begin":368,"end":374},"obj":"\"http://rdf.glycoinfo.org/glycan/G26693XF\""},{"id":"GlycanIUPAC_T4","span":{"begin":1020,"end":1026},"obj":"\"http://rdf.glycoinfo.org/glycan/G26693XF\""},{"id":"GlycanIUPAC_T5","span":{"begin":1154,"end":1160},"obj":"\"http://rdf.glycoinfo.org/glycan/G26693XF\""},{"id":"GlycanIUPAC_T6","span":{"begin":1406,"end":1412},"obj":"\"http://rdf.glycoinfo.org/glycan/G26693XF\""},{"id":"GlycanIUPAC_T7","span":{"begin":1478,"end":1484},"obj":"\"http://rdf.glycoinfo.org/glycan/G26693XF\""},{"id":"GlycanIUPAC_T8","span":{"begin":2,"end":8},"obj":"\"http://rdf.glycoinfo.org/glycan/G01864SU\""},{"id":"GlycanIUPAC_T9","span":{"begin":313,"end":319},"obj":"\"http://rdf.glycoinfo.org/glycan/G01864SU\""},{"id":"GlycanIUPAC_T10","span":{"begin":368,"end":374},"obj":"\"http://rdf.glycoinfo.org/glycan/G01864SU\""},{"id":"GlycanIUPAC_T11","span":{"begin":1020,"end":1026},"obj":"\"http://rdf.glycoinfo.org/glycan/G01864SU\""},{"id":"GlycanIUPAC_T12","span":{"begin":1154,"end":1160},"obj":"\"http://rdf.glycoinfo.org/glycan/G01864SU\""},{"id":"GlycanIUPAC_T13","span":{"begin":1406,"end":1412},"obj":"\"http://rdf.glycoinfo.org/glycan/G01864SU\""},{"id":"GlycanIUPAC_T14","span":{"begin":1478,"end":1484},"obj":"\"http://rdf.glycoinfo.org/glycan/G01864SU\""},{"id":"GlycanIUPAC_T15","span":{"begin":2,"end":8},"obj":"\"http://rdf.glycoinfo.org/glycan/G17605FD\""},{"id":"GlycanIUPAC_T16","span":{"begin":313,"end":319},"obj":"\"http://rdf.glycoinfo.org/glycan/G17605FD\""},{"id":"GlycanIUPAC_T17","span":{"begin":368,"end":374},"obj":"\"http://rdf.glycoinfo.org/glycan/G17605FD\""},{"id":"GlycanIUPAC_T18","span":{"begin":1020,"end":1026},"obj":"\"http://rdf.glycoinfo.org/glycan/G17605FD\""},{"id":"GlycanIUPAC_T19","span":{"begin":1154,"end":1160},"obj":"\"http://rdf.glycoinfo.org/glycan/G17605FD\""},{"id":"GlycanIUPAC_T20","span":{"begin":1406,"end":1412},"obj":"\"http://rdf.glycoinfo.org/glycan/G17605FD\""},{"id":"GlycanIUPAC_T21","span":{"begin":1478,"end":1484},"obj":"\"http://rdf.glycoinfo.org/glycan/G17605FD\""},{"id":"GlycanIUPAC_T22","span":{"begin":2,"end":8},"obj":"\"http://rdf.glycoinfo.org/glycan/G41950LU\""},{"id":"GlycanIUPAC_T23","span":{"begin":313,"end":319},"obj":"\"http://rdf.glycoinfo.org/glycan/G41950LU\""},{"id":"GlycanIUPAC_T24","span":{"begin":368,"end":374},"obj":"\"http://rdf.glycoinfo.org/glycan/G41950LU\""},{"id":"GlycanIUPAC_T25","span":{"begin":1020,"end":1026},"obj":"\"http://rdf.glycoinfo.org/glycan/G41950LU\""},{"id":"GlycanIUPAC_T26","span":{"begin":1154,"end":1160},"obj":"\"http://rdf.glycoinfo.org/glycan/G41950LU\""},{"id":"GlycanIUPAC_T27","span":{"begin":1406,"end":1412},"obj":"\"http://rdf.glycoinfo.org/glycan/G41950LU\""},{"id":"GlycanIUPAC_T28","span":{"begin":1478,"end":1484},"obj":"\"http://rdf.glycoinfo.org/glycan/G41950LU\""},{"id":"GlycanIUPAC_T29","span":{"begin":2,"end":8},"obj":"\"http://rdf.glycoinfo.org/glycan/G57195RJ\""},{"id":"GlycanIUPAC_T30","span":{"begin":313,"end":319},"obj":"\"http://rdf.glycoinfo.org/glycan/G57195RJ\""},{"id":"GlycanIUPAC_T31","span":{"begin":368,"end":374},"obj":"\"http://rdf.glycoinfo.org/glycan/G57195RJ\""},{"id":"GlycanIUPAC_T32","span":{"begin":1020,"end":1026},"obj":"\"http://rdf.glycoinfo.org/glycan/G57195RJ\""},{"id":"GlycanIUPAC_T33","span":{"begin":1154,"end":1160},"obj":"\"http://rdf.glycoinfo.org/glycan/G57195RJ\""},{"id":"GlycanIUPAC_T34","span":{"begin":1406,"end":1412},"obj":"\"http://rdf.glycoinfo.org/glycan/G57195RJ\""},{"id":"GlycanIUPAC_T35","span":{"begin":1478,"end":1484},"obj":"\"http://rdf.glycoinfo.org/glycan/G57195RJ\""},{"id":"GlycanIUPAC_T36","span":{"begin":2,"end":8},"obj":"\"http://rdf.glycoinfo.org/glycan/G85391SA\""},{"id":"GlycanIUPAC_T37","span":{"begin":313,"end":319},"obj":"\"http://rdf.glycoinfo.org/glycan/G85391SA\""},{"id":"GlycanIUPAC_T38","span":{"begin":368,"end":374},"obj":"\"http://rdf.glycoinfo.org/glycan/G85391SA\""},{"id":"GlycanIUPAC_T39","span":{"begin":1020,"end":1026},"obj":"\"http://rdf.glycoinfo.org/glycan/G85391SA\""},{"id":"GlycanIUPAC_T40","span":{"begin":1154,"end":1160},"obj":"\"http://rdf.glycoinfo.org/glycan/G85391SA\""},{"id":"GlycanIUPAC_T41","span":{"begin":1406,"end":1412},"obj":"\"http://rdf.glycoinfo.org/glycan/G85391SA\""},{"id":"GlycanIUPAC_T42","span":{"begin":1478,"end":1484},"obj":"\"http://rdf.glycoinfo.org/glycan/G85391SA\""},{"id":"GlycanIUPAC_T43","span":{"begin":2,"end":8},"obj":"\"http://rdf.glycoinfo.org/glycan/G89565QL\""},{"id":"GlycanIUPAC_T44","span":{"begin":313,"end":319},"obj":"\"http://rdf.glycoinfo.org/glycan/G89565QL\""},{"id":"GlycanIUPAC_T45","span":{"begin":368,"end":374},"obj":"\"http://rdf.glycoinfo.org/glycan/G89565QL\""},{"id":"GlycanIUPAC_T46","span":{"begin":1020,"end":1026},"obj":"\"http://rdf.glycoinfo.org/glycan/G89565QL\""},{"id":"GlycanIUPAC_T47","span":{"begin":1154,"end":1160},"obj":"\"http://rdf.glycoinfo.org/glycan/G89565QL\""},{"id":"GlycanIUPAC_T48","span":{"begin":1406,"end":1412},"obj":"\"http://rdf.glycoinfo.org/glycan/G89565QL\""},{"id":"GlycanIUPAC_T49","span":{"begin":1478,"end":1484},"obj":"\"http://rdf.glycoinfo.org/glycan/G89565QL\""},{"id":"GlycanIUPAC_T50","span":{"begin":2,"end":8},"obj":"\"http://rdf.glycoinfo.org/glycan/G80869MR\""},{"id":"GlycanIUPAC_T51","span":{"begin":313,"end":319},"obj":"\"http://rdf.glycoinfo.org/glycan/G80869MR\""},{"id":"GlycanIUPAC_T52","span":{"begin":368,"end":374},"obj":"\"http://rdf.glycoinfo.org/glycan/G80869MR\""},{"id":"GlycanIUPAC_T53","span":{"begin":1020,"end":1026},"obj":"\"http://rdf.glycoinfo.org/glycan/G80869MR\""},{"id":"GlycanIUPAC_T54","span":{"begin":1154,"end":1160},"obj":"\"http://rdf.glycoinfo.org/glycan/G80869MR\""},{"id":"GlycanIUPAC_T55","span":{"begin":1406,"end":1412},"obj":"\"http://rdf.glycoinfo.org/glycan/G80869MR\""},{"id":"GlycanIUPAC_T56","span":{"begin":1478,"end":1484},"obj":"\"http://rdf.glycoinfo.org/glycan/G80869MR\""},{"id":"GlycanIUPAC_T57","span":{"begin":2,"end":8},"obj":"\"http://rdf.glycoinfo.org/glycan/G55978NL\""},{"id":"GlycanIUPAC_T58","span":{"begin":313,"end":319},"obj":"\"http://rdf.glycoinfo.org/glycan/G55978NL\""},{"id":"GlycanIUPAC_T59","span":{"begin":368,"end":374},"obj":"\"http://rdf.glycoinfo.org/glycan/G55978NL\""},{"id":"GlycanIUPAC_T60","span":{"begin":1020,"end":1026},"obj":"\"http://rdf.glycoinfo.org/glycan/G55978NL\""},{"id":"GlycanIUPAC_T61","span":{"begin":1154,"end":1160},"obj":"\"http://rdf.glycoinfo.org/glycan/G55978NL\""},{"id":"GlycanIUPAC_T62","span":{"begin":1406,"end":1412},"obj":"\"http://rdf.glycoinfo.org/glycan/G55978NL\""},{"id":"GlycanIUPAC_T63","span":{"begin":1478,"end":1484},"obj":"\"http://rdf.glycoinfo.org/glycan/G55978NL\""},{"id":"GlycanIUPAC_T64","span":{"begin":2,"end":8},"obj":"\"http://rdf.glycoinfo.org/glycan/G54644LT\""},{"id":"GlycanIUPAC_T65","span":{"begin":313,"end":319},"obj":"\"http://rdf.glycoinfo.org/glycan/G54644LT\""},{"id":"GlycanIUPAC_T66","span":{"begin":368,"end":374},"obj":"\"http://rdf.glycoinfo.org/glycan/G54644LT\""},{"id":"GlycanIUPAC_T67","span":{"begin":1020,"end":1026},"obj":"\"http://rdf.glycoinfo.org/glycan/G54644LT\""},{"id":"GlycanIUPAC_T68","span":{"begin":1154,"end":1160},"obj":"\"http://rdf.glycoinfo.org/glycan/G54644LT\""},{"id":"GlycanIUPAC_T69","span":{"begin":1406,"end":1412},"obj":"\"http://rdf.glycoinfo.org/glycan/G54644LT\""},{"id":"GlycanIUPAC_T70","span":{"begin":1478,"end":1484},"obj":"\"http://rdf.glycoinfo.org/glycan/G54644LT\""},{"id":"GlycanIUPAC_T71","span":{"begin":2,"end":8},"obj":"\"http://rdf.glycoinfo.org/glycan/G25694UG\""},{"id":"GlycanIUPAC_T72","span":{"begin":313,"end":319},"obj":"\"http://rdf.glycoinfo.org/glycan/G25694UG\""},{"id":"GlycanIUPAC_T73","span":{"begin":368,"end":374},"obj":"\"http://rdf.glycoinfo.org/glycan/G25694UG\""},{"id":"GlycanIUPAC_T74","span":{"begin":1020,"end":1026},"obj":"\"http://rdf.glycoinfo.org/glycan/G25694UG\""},{"id":"GlycanIUPAC_T75","span":{"begin":1154,"end":1160},"obj":"\"http://rdf.glycoinfo.org/glycan/G25694UG\""},{"id":"GlycanIUPAC_T76","span":{"begin":1406,"end":1412},"obj":"\"http://rdf.glycoinfo.org/glycan/G25694UG\""},{"id":"GlycanIUPAC_T77","span":{"begin":1478,"end":1484},"obj":"\"http://rdf.glycoinfo.org/glycan/G25694UG\""},{"id":"GlycanIUPAC_T78","span":{"begin":2,"end":8},"obj":"\"http://rdf.glycoinfo.org/glycan/G25126RB\""},{"id":"GlycanIUPAC_T79","span":{"begin":313,"end":319},"obj":"\"http://rdf.glycoinfo.org/glycan/G25126RB\""},{"id":"GlycanIUPAC_T80","span":{"begin":368,"end":374},"obj":"\"http://rdf.glycoinfo.org/glycan/G25126RB\""},{"id":"GlycanIUPAC_T81","span":{"begin":1020,"end":1026},"obj":"\"http://rdf.glycoinfo.org/glycan/G25126RB\""},{"id":"GlycanIUPAC_T82","span":{"begin":1154,"end":1160},"obj":"\"http://rdf.glycoinfo.org/glycan/G25126RB\""},{"id":"GlycanIUPAC_T83","span":{"begin":1406,"end":1412},"obj":"\"http://rdf.glycoinfo.org/glycan/G25126RB\""},{"id":"GlycanIUPAC_T84","span":{"begin":1478,"end":1484},"obj":"\"http://rdf.glycoinfo.org/glycan/G25126RB\""},{"id":"GlycanIUPAC_T85","span":{"begin":2,"end":8},"obj":"\"http://rdf.glycoinfo.org/glycan/G51848AD\""},{"id":"GlycanIUPAC_T86","span":{"begin":313,"end":319},"obj":"\"http://rdf.glycoinfo.org/glycan/G51848AD\""},{"id":"GlycanIUPAC_T87","span":{"begin":368,"end":374},"obj":"\"http://rdf.glycoinfo.org/glycan/G51848AD\""},{"id":"GlycanIUPAC_T88","span":{"begin":1020,"end":1026},"obj":"\"http://rdf.glycoinfo.org/glycan/G51848AD\""},{"id":"GlycanIUPAC_T89","span":{"begin":1154,"end":1160},"obj":"\"http://rdf.glycoinfo.org/glycan/G51848AD\""},{"id":"GlycanIUPAC_T90","span":{"begin":1406,"end":1412},"obj":"\"http://rdf.glycoinfo.org/glycan/G51848AD\""},{"id":"GlycanIUPAC_T91","span":{"begin":1478,"end":1484},"obj":"\"http://rdf.glycoinfo.org/glycan/G51848AD\""},{"id":"GlycanIUPAC_T92","span":{"begin":2,"end":8},"obj":"\"http://rdf.glycoinfo.org/glycan/G94667GM\""},{"id":"GlycanIUPAC_T93","span":{"begin":313,"end":319},"obj":"\"http://rdf.glycoinfo.org/glycan/G94667GM\""},{"id":"GlycanIUPAC_T94","span":{"begin":368,"end":374},"obj":"\"http://rdf.glycoinfo.org/glycan/G94667GM\""},{"id":"GlycanIUPAC_T95","span":{"begin":1020,"end":1026},"obj":"\"http://rdf.glycoinfo.org/glycan/G94667GM\""},{"id":"GlycanIUPAC_T96","span":{"begin":1154,"end":1160},"obj":"\"http://rdf.glycoinfo.org/glycan/G94667GM\""},{"id":"GlycanIUPAC_T97","span":{"begin":1406,"end":1412},"obj":"\"http://rdf.glycoinfo.org/glycan/G94667GM\""},{"id":"GlycanIUPAC_T98","span":{"begin":1478,"end":1484},"obj":"\"http://rdf.glycoinfo.org/glycan/G94667GM\""},{"id":"GlycanIUPAC_T99","span":{"begin":2,"end":8},"obj":"\"http://rdf.glycoinfo.org/glycan/G30124BO\""},{"id":"GlycanIUPAC_T100","span":{"begin":313,"end":319},"obj":"\"http://rdf.glycoinfo.org/glycan/G30124BO\""},{"id":"GlycanIUPAC_T101","span":{"begin":368,"end":374},"obj":"\"http://rdf.glycoinfo.org/glycan/G30124BO\""},{"id":"GlycanIUPAC_T102","span":{"begin":1020,"end":1026},"obj":"\"http://rdf.glycoinfo.org/glycan/G30124BO\""},{"id":"GlycanIUPAC_T103","span":{"begin":1154,"end":1160},"obj":"\"http://rdf.glycoinfo.org/glycan/G30124BO\""},{"id":"GlycanIUPAC_T104","span":{"begin":1406,"end":1412},"obj":"\"http://rdf.glycoinfo.org/glycan/G30124BO\""},{"id":"GlycanIUPAC_T105","span":{"begin":1478,"end":1484},"obj":"\"http://rdf.glycoinfo.org/glycan/G30124BO\""},{"id":"GlycanIUPAC_T106","span":{"begin":2,"end":8},"obj":"\"http://rdf.glycoinfo.org/glycan/G82777EZ\""},{"id":"GlycanIUPAC_T107","span":{"begin":313,"end":319},"obj":"\"http://rdf.glycoinfo.org/glycan/G82777EZ\""},{"id":"GlycanIUPAC_T108","span":{"begin":368,"end":374},"obj":"\"http://rdf.glycoinfo.org/glycan/G82777EZ\""},{"id":"GlycanIUPAC_T109","span":{"begin":1020,"end":1026},"obj":"\"http://rdf.glycoinfo.org/glycan/G82777EZ\""},{"id":"GlycanIUPAC_T110","span":{"begin":1154,"end":1160},"obj":"\"http://rdf.glycoinfo.org/glycan/G82777EZ\""},{"id":"GlycanIUPAC_T111","span":{"begin":1406,"end":1412},"obj":"\"http://rdf.glycoinfo.org/glycan/G82777EZ\""},{"id":"GlycanIUPAC_T112","span":{"begin":1478,"end":1484},"obj":"\"http://rdf.glycoinfo.org/glycan/G82777EZ\""},{"id":"GlycanIUPAC_T113","span":{"begin":2,"end":8},"obj":"\"http://rdf.glycoinfo.org/glycan/G10151YZ\""},{"id":"GlycanIUPAC_T114","span":{"begin":313,"end":319},"obj":"\"http://rdf.glycoinfo.org/glycan/G10151YZ\""},{"id":"GlycanIUPAC_T115","span":{"begin":368,"end":374},"obj":"\"http://rdf.glycoinfo.org/glycan/G10151YZ\""},{"id":"GlycanIUPAC_T116","span":{"begin":1020,"end":1026},"obj":"\"http://rdf.glycoinfo.org/glycan/G10151YZ\""},{"id":"GlycanIUPAC_T117","span":{"begin":1154,"end":1160},"obj":"\"http://rdf.glycoinfo.org/glycan/G10151YZ\""},{"id":"GlycanIUPAC_T118","span":{"begin":1406,"end":1412},"obj":"\"http://rdf.glycoinfo.org/glycan/G10151YZ\""},{"id":"GlycanIUPAC_T119","span":{"begin":1478,"end":1484},"obj":"\"http://rdf.glycoinfo.org/glycan/G10151YZ\""},{"id":"GlycanIUPAC_T120","span":{"begin":2,"end":8},"obj":"\"http://rdf.glycoinfo.org/glycan/G17585ZM\""},{"id":"GlycanIUPAC_T121","span":{"begin":313,"end":319},"obj":"\"http://rdf.glycoinfo.org/glycan/G17585ZM\""},{"id":"GlycanIUPAC_T122","span":{"begin":368,"end":374},"obj":"\"http://rdf.glycoinfo.org/glycan/G17585ZM\""},{"id":"GlycanIUPAC_T123","span":{"begin":1020,"end":1026},"obj":"\"http://rdf.glycoinfo.org/glycan/G17585ZM\""},{"id":"GlycanIUPAC_T124","span":{"begin":1154,"end":1160},"obj":"\"http://rdf.glycoinfo.org/glycan/G17585ZM\""},{"id":"GlycanIUPAC_T125","span":{"begin":1406,"end":1412},"obj":"\"http://rdf.glycoinfo.org/glycan/G17585ZM\""},{"id":"GlycanIUPAC_T126","span":{"begin":1478,"end":1484},"obj":"\"http://rdf.glycoinfo.org/glycan/G17585ZM\""},{"id":"GlycanIUPAC_T127","span":{"begin":2,"end":8},"obj":"\"http://rdf.glycoinfo.org/glycan/G04411CJ\""},{"id":"GlycanIUPAC_T128","span":{"begin":313,"end":319},"obj":"\"http://rdf.glycoinfo.org/glycan/G04411CJ\""},{"id":"GlycanIUPAC_T129","span":{"begin":368,"end":374},"obj":"\"http://rdf.glycoinfo.org/glycan/G04411CJ\""},{"id":"GlycanIUPAC_T130","span":{"begin":1020,"end":1026},"obj":"\"http://rdf.glycoinfo.org/glycan/G04411CJ\""},{"id":"GlycanIUPAC_T131","span":{"begin":1154,"end":1160},"obj":"\"http://rdf.glycoinfo.org/glycan/G04411CJ\""},{"id":"GlycanIUPAC_T132","span":{"begin":1406,"end":1412},"obj":"\"http://rdf.glycoinfo.org/glycan/G04411CJ\""},{"id":"GlycanIUPAC_T133","span":{"begin":1478,"end":1484},"obj":"\"http://rdf.glycoinfo.org/glycan/G04411CJ\""},{"id":"GlycanIUPAC_T134","span":{"begin":2,"end":8},"obj":"\"http://rdf.glycoinfo.org/glycan/G38254HJ\""},{"id":"GlycanIUPAC_T135","span":{"begin":313,"end":319},"obj":"\"http://rdf.glycoinfo.org/glycan/G38254HJ\""},{"id":"GlycanIUPAC_T136","span":{"begin":368,"end":374},"obj":"\"http://rdf.glycoinfo.org/glycan/G38254HJ\""},{"id":"GlycanIUPAC_T137","span":{"begin":1020,"end":1026},"obj":"\"http://rdf.glycoinfo.org/glycan/G38254HJ\""},{"id":"GlycanIUPAC_T138","span":{"begin":1154,"end":1160},"obj":"\"http://rdf.glycoinfo.org/glycan/G38254HJ\""},{"id":"GlycanIUPAC_T139","span":{"begin":1406,"end":1412},"obj":"\"http://rdf.glycoinfo.org/glycan/G38254HJ\""},{"id":"GlycanIUPAC_T140","span":{"begin":1478,"end":1484},"obj":"\"http://rdf.glycoinfo.org/glycan/G38254HJ\""},{"id":"GlycanIUPAC_T141","span":{"begin":2,"end":8},"obj":"\"http://rdf.glycoinfo.org/glycan/G75188FS\""},{"id":"GlycanIUPAC_T142","span":{"begin":313,"end":319},"obj":"\"http://rdf.glycoinfo.org/glycan/G75188FS\""},{"id":"GlycanIUPAC_T143","span":{"begin":368,"end":374},"obj":"\"http://rdf.glycoinfo.org/glycan/G75188FS\""},{"id":"GlycanIUPAC_T144","span":{"begin":1020,"end":1026},"obj":"\"http://rdf.glycoinfo.org/glycan/G75188FS\""},{"id":"GlycanIUPAC_T145","span":{"begin":1154,"end":1160},"obj":"\"http://rdf.glycoinfo.org/glycan/G75188FS\""},{"id":"GlycanIUPAC_T146","span":{"begin":1406,"end":1412},"obj":"\"http://rdf.glycoinfo.org/glycan/G75188FS\""},{"id":"GlycanIUPAC_T147","span":{"begin":1478,"end":1484},"obj":"\"http://rdf.glycoinfo.org/glycan/G75188FS\""},{"id":"GlycanIUPAC_T148","span":{"begin":2,"end":8},"obj":"\"http://rdf.glycoinfo.org/glycan/G70374VG\""},{"id":"GlycanIUPAC_T149","span":{"begin":313,"end":319},"obj":"\"http://rdf.glycoinfo.org/glycan/G70374VG\""},{"id":"GlycanIUPAC_T150","span":{"begin":368,"end":374},"obj":"\"http://rdf.glycoinfo.org/glycan/G70374VG\""},{"id":"GlycanIUPAC_T151","span":{"begin":1020,"end":1026},"obj":"\"http://rdf.glycoinfo.org/glycan/G70374VG\""},{"id":"GlycanIUPAC_T152","span":{"begin":1154,"end":1160},"obj":"\"http://rdf.glycoinfo.org/glycan/G70374VG\""},{"id":"GlycanIUPAC_T153","span":{"begin":1406,"end":1412},"obj":"\"http://rdf.glycoinfo.org/glycan/G70374VG\""},{"id":"GlycanIUPAC_T154","span":{"begin":1478,"end":1484},"obj":"\"http://rdf.glycoinfo.org/glycan/G70374VG\""},{"id":"GlycanIUPAC_T155","span":{"begin":2,"end":8},"obj":"\"http://rdf.glycoinfo.org/glycan/G45176LJ\""},{"id":"GlycanIUPAC_T156","span":{"begin":313,"end":319},"obj":"\"http://rdf.glycoinfo.org/glycan/G45176LJ\""},{"id":"GlycanIUPAC_T157","span":{"begin":368,"end":374},"obj":"\"http://rdf.glycoinfo.org/glycan/G45176LJ\""},{"id":"GlycanIUPAC_T158","span":{"begin":1020,"end":1026},"obj":"\"http://rdf.glycoinfo.org/glycan/G45176LJ\""},{"id":"GlycanIUPAC_T159","span":{"begin":1154,"end":1160},"obj":"\"http://rdf.glycoinfo.org/glycan/G45176LJ\""},{"id":"GlycanIUPAC_T160","span":{"begin":1406,"end":1412},"obj":"\"http://rdf.glycoinfo.org/glycan/G45176LJ\""},{"id":"GlycanIUPAC_T161","span":{"begin":1478,"end":1484},"obj":"\"http://rdf.glycoinfo.org/glycan/G45176LJ\""},{"id":"GlycanIUPAC_T162","span":{"begin":2,"end":8},"obj":"\"http://rdf.glycoinfo.org/glycan/G30874VW\""},{"id":"GlycanIUPAC_T163","span":{"begin":313,"end":319},"obj":"\"http://rdf.glycoinfo.org/glycan/G30874VW\""},{"id":"GlycanIUPAC_T164","span":{"begin":368,"end":374},"obj":"\"http://rdf.glycoinfo.org/glycan/G30874VW\""},{"id":"GlycanIUPAC_T165","span":{"begin":1020,"end":1026},"obj":"\"http://rdf.glycoinfo.org/glycan/G30874VW\""},{"id":"GlycanIUPAC_T166","span":{"begin":1154,"end":1160},"obj":"\"http://rdf.glycoinfo.org/glycan/G30874VW\""},{"id":"GlycanIUPAC_T167","span":{"begin":1406,"end":1412},"obj":"\"http://rdf.glycoinfo.org/glycan/G30874VW\""},{"id":"GlycanIUPAC_T168","span":{"begin":1478,"end":1484},"obj":"\"http://rdf.glycoinfo.org/glycan/G30874VW\""},{"id":"GlycanIUPAC_T169","span":{"begin":2,"end":8},"obj":"\"http://rdf.glycoinfo.org/glycan/G69333MI\""},{"id":"GlycanIUPAC_T170","span":{"begin":313,"end":319},"obj":"\"http://rdf.glycoinfo.org/glycan/G69333MI\""},{"id":"GlycanIUPAC_T171","span":{"begin":368,"end":374},"obj":"\"http://rdf.glycoinfo.org/glycan/G69333MI\""},{"id":"GlycanIUPAC_T172","span":{"begin":1020,"end":1026},"obj":"\"http://rdf.glycoinfo.org/glycan/G69333MI\""},{"id":"GlycanIUPAC_T173","span":{"begin":1154,"end":1160},"obj":"\"http://rdf.glycoinfo.org/glycan/G69333MI\""},{"id":"GlycanIUPAC_T174","span":{"begin":1406,"end":1412},"obj":"\"http://rdf.glycoinfo.org/glycan/G69333MI\""},{"id":"GlycanIUPAC_T175","span":{"begin":1478,"end":1484},"obj":"\"http://rdf.glycoinfo.org/glycan/G69333MI\""},{"id":"GlycanIUPAC_T176","span":{"begin":2,"end":8},"obj":"\"http://rdf.glycoinfo.org/glycan/G10676XO\""},{"id":"GlycanIUPAC_T177","span":{"begin":313,"end":319},"obj":"\"http://rdf.glycoinfo.org/glycan/G10676XO\""},{"id":"GlycanIUPAC_T178","span":{"begin":368,"end":374},"obj":"\"http://rdf.glycoinfo.org/glycan/G10676XO\""},{"id":"GlycanIUPAC_T179","span":{"begin":1020,"end":1026},"obj":"\"http://rdf.glycoinfo.org/glycan/G10676XO\""},{"id":"GlycanIUPAC_T180","span":{"begin":1154,"end":1160},"obj":"\"http://rdf.glycoinfo.org/glycan/G10676XO\""},{"id":"GlycanIUPAC_T181","span":{"begin":1406,"end":1412},"obj":"\"http://rdf.glycoinfo.org/glycan/G10676XO\""},{"id":"GlycanIUPAC_T182","span":{"begin":1478,"end":1484},"obj":"\"http://rdf.glycoinfo.org/glycan/G10676XO\""},{"id":"GlycanIUPAC_T183","span":{"begin":2,"end":8},"obj":"\"http://rdf.glycoinfo.org/glycan/G14843DJ\""},{"id":"GlycanIUPAC_T184","span":{"begin":313,"end":319},"obj":"\"http://rdf.glycoinfo.org/glycan/G14843DJ\""},{"id":"GlycanIUPAC_T185","span":{"begin":368,"end":374},"obj":"\"http://rdf.glycoinfo.org/glycan/G14843DJ\""},{"id":"GlycanIUPAC_T186","span":{"begin":1020,"end":1026},"obj":"\"http://rdf.glycoinfo.org/glycan/G14843DJ\""},{"id":"GlycanIUPAC_T187","span":{"begin":1154,"end":1160},"obj":"\"http://rdf.glycoinfo.org/glycan/G14843DJ\""},{"id":"GlycanIUPAC_T188","span":{"begin":1406,"end":1412},"obj":"\"http://rdf.glycoinfo.org/glycan/G14843DJ\""},{"id":"GlycanIUPAC_T189","span":{"begin":1478,"end":1484},"obj":"\"http://rdf.glycoinfo.org/glycan/G14843DJ\""},{"id":"GlycanIUPAC_T190","span":{"begin":2,"end":8},"obj":"\"http://rdf.glycoinfo.org/glycan/G47546FR\""},{"id":"GlycanIUPAC_T191","span":{"begin":313,"end":319},"obj":"\"http://rdf.glycoinfo.org/glycan/G47546FR\""},{"id":"GlycanIUPAC_T192","span":{"begin":368,"end":374},"obj":"\"http://rdf.glycoinfo.org/glycan/G47546FR\""},{"id":"GlycanIUPAC_T193","span":{"begin":1020,"end":1026},"obj":"\"http://rdf.glycoinfo.org/glycan/G47546FR\""},{"id":"GlycanIUPAC_T194","span":{"begin":1154,"end":1160},"obj":"\"http://rdf.glycoinfo.org/glycan/G47546FR\""},{"id":"GlycanIUPAC_T195","span":{"begin":1406,"end":1412},"obj":"\"http://rdf.glycoinfo.org/glycan/G47546FR\""},{"id":"GlycanIUPAC_T196","span":{"begin":1478,"end":1484},"obj":"\"http://rdf.glycoinfo.org/glycan/G47546FR\""},{"id":"GlycanIUPAC_T197","span":{"begin":2,"end":8},"obj":"\"http://rdf.glycoinfo.org/glycan/G73695ZM\""},{"id":"GlycanIUPAC_T198","span":{"begin":313,"end":319},"obj":"\"http://rdf.glycoinfo.org/glycan/G73695ZM\""},{"id":"GlycanIUPAC_T199","span":{"begin":368,"end":374},"obj":"\"http://rdf.glycoinfo.org/glycan/G73695ZM\""},{"id":"GlycanIUPAC_T200","span":{"begin":1020,"end":1026},"obj":"\"http://rdf.glycoinfo.org/glycan/G73695ZM\""},{"id":"GlycanIUPAC_T201","span":{"begin":1154,"end":1160},"obj":"\"http://rdf.glycoinfo.org/glycan/G73695ZM\""},{"id":"GlycanIUPAC_T202","span":{"begin":1406,"end":1412},"obj":"\"http://rdf.glycoinfo.org/glycan/G73695ZM\""},{"id":"GlycanIUPAC_T203","span":{"begin":1478,"end":1484},"obj":"\"http://rdf.glycoinfo.org/glycan/G73695ZM\""},{"id":"GlycanIUPAC_T204","span":{"begin":2,"end":8},"obj":"\"http://rdf.glycoinfo.org/glycan/G31923TJ\""},{"id":"GlycanIUPAC_T205","span":{"begin":313,"end":319},"obj":"\"http://rdf.glycoinfo.org/glycan/G31923TJ\""},{"id":"GlycanIUPAC_T206","span":{"begin":368,"end":374},"obj":"\"http://rdf.glycoinfo.org/glycan/G31923TJ\""},{"id":"GlycanIUPAC_T207","span":{"begin":1020,"end":1026},"obj":"\"http://rdf.glycoinfo.org/glycan/G31923TJ\""},{"id":"GlycanIUPAC_T208","span":{"begin":1154,"end":1160},"obj":"\"http://rdf.glycoinfo.org/glycan/G31923TJ\""},{"id":"GlycanIUPAC_T209","span":{"begin":1406,"end":1412},"obj":"\"http://rdf.glycoinfo.org/glycan/G31923TJ\""},{"id":"GlycanIUPAC_T210","span":{"begin":1478,"end":1484},"obj":"\"http://rdf.glycoinfo.org/glycan/G31923TJ\""},{"id":"GlycanIUPAC_T211","span":{"begin":2,"end":8},"obj":"\"http://rdf.glycoinfo.org/glycan/G60519EP\""},{"id":"GlycanIUPAC_T212","span":{"begin":313,"end":319},"obj":"\"http://rdf.glycoinfo.org/glycan/G60519EP\""},{"id":"GlycanIUPAC_T213","span":{"begin":368,"end":374},"obj":"\"http://rdf.glycoinfo.org/glycan/G60519EP\""},{"id":"GlycanIUPAC_T214","span":{"begin":1020,"end":1026},"obj":"\"http://rdf.glycoinfo.org/glycan/G60519EP\""},{"id":"GlycanIUPAC_T215","span":{"begin":1154,"end":1160},"obj":"\"http://rdf.glycoinfo.org/glycan/G60519EP\""},{"id":"GlycanIUPAC_T216","span":{"begin":1406,"end":1412},"obj":"\"http://rdf.glycoinfo.org/glycan/G60519EP\""},{"id":"GlycanIUPAC_T217","span":{"begin":1478,"end":1484},"obj":"\"http://rdf.glycoinfo.org/glycan/G60519EP\""},{"id":"GlycanIUPAC_T218","span":{"begin":2,"end":8},"obj":"\"http://rdf.glycoinfo.org/glycan/G07933IA\""},{"id":"GlycanIUPAC_T219","span":{"begin":313,"end":319},"obj":"\"http://rdf.glycoinfo.org/glycan/G07933IA\""},{"id":"GlycanIUPAC_T220","span":{"begin":368,"end":374},"obj":"\"http://rdf.glycoinfo.org/glycan/G07933IA\""},{"id":"GlycanIUPAC_T221","span":{"begin":1020,"end":1026},"obj":"\"http://rdf.glycoinfo.org/glycan/G07933IA\""},{"id":"GlycanIUPAC_T222","span":{"begin":1154,"end":1160},"obj":"\"http://rdf.glycoinfo.org/glycan/G07933IA\""},{"id":"GlycanIUPAC_T223","span":{"begin":1406,"end":1412},"obj":"\"http://rdf.glycoinfo.org/glycan/G07933IA\""},{"id":"GlycanIUPAC_T224","span":{"begin":1478,"end":1484},"obj":"\"http://rdf.glycoinfo.org/glycan/G07933IA\""},{"id":"GlycanIUPAC_T225","span":{"begin":2,"end":8},"obj":"\"http://rdf.glycoinfo.org/glycan/G40745NH\""},{"id":"GlycanIUPAC_T226","span":{"begin":313,"end":319},"obj":"\"http://rdf.glycoinfo.org/glycan/G40745NH\""},{"id":"GlycanIUPAC_T227","span":{"begin":368,"end":374},"obj":"\"http://rdf.glycoinfo.org/glycan/G40745NH\""},{"id":"GlycanIUPAC_T228","span":{"begin":1020,"end":1026},"obj":"\"http://rdf.glycoinfo.org/glycan/G40745NH\""},{"id":"GlycanIUPAC_T229","span":{"begin":1154,"end":1160},"obj":"\"http://rdf.glycoinfo.org/glycan/G40745NH\""},{"id":"GlycanIUPAC_T230","span":{"begin":1406,"end":1412},"obj":"\"http://rdf.glycoinfo.org/glycan/G40745NH\""},{"id":"GlycanIUPAC_T231","span":{"begin":1478,"end":1484},"obj":"\"http://rdf.glycoinfo.org/glycan/G40745NH\""},{"id":"GlycanIUPAC_T232","span":{"begin":2,"end":8},"obj":"\"http://rdf.glycoinfo.org/glycan/G54496YV\""},{"id":"GlycanIUPAC_T233","span":{"begin":313,"end":319},"obj":"\"http://rdf.glycoinfo.org/glycan/G54496YV\""},{"id":"GlycanIUPAC_T234","span":{"begin":368,"end":374},"obj":"\"http://rdf.glycoinfo.org/glycan/G54496YV\""},{"id":"GlycanIUPAC_T235","span":{"begin":1020,"end":1026},"obj":"\"http://rdf.glycoinfo.org/glycan/G54496YV\""},{"id":"GlycanIUPAC_T236","span":{"begin":1154,"end":1160},"obj":"\"http://rdf.glycoinfo.org/glycan/G54496YV\""},{"id":"GlycanIUPAC_T237","span":{"begin":1406,"end":1412},"obj":"\"http://rdf.glycoinfo.org/glycan/G54496YV\""},{"id":"GlycanIUPAC_T238","span":{"begin":1478,"end":1484},"obj":"\"http://rdf.glycoinfo.org/glycan/G54496YV\""},{"id":"GlycanIUPAC_T239","span":{"begin":2,"end":8},"obj":"\"http://rdf.glycoinfo.org/glycan/G62953SQ\""},{"id":"GlycanIUPAC_T240","span":{"begin":313,"end":319},"obj":"\"http://rdf.glycoinfo.org/glycan/G62953SQ\""},{"id":"GlycanIUPAC_T241","span":{"begin":368,"end":374},"obj":"\"http://rdf.glycoinfo.org/glycan/G62953SQ\""},{"id":"GlycanIUPAC_T242","span":{"begin":1020,"end":1026},"obj":"\"http://rdf.glycoinfo.org/glycan/G62953SQ\""},{"id":"GlycanIUPAC_T243","span":{"begin":1154,"end":1160},"obj":"\"http://rdf.glycoinfo.org/glycan/G62953SQ\""},{"id":"GlycanIUPAC_T244","span":{"begin":1406,"end":1412},"obj":"\"http://rdf.glycoinfo.org/glycan/G62953SQ\""},{"id":"GlycanIUPAC_T245","span":{"begin":1478,"end":1484},"obj":"\"http://rdf.glycoinfo.org/glycan/G62953SQ\""},{"id":"GlycanIUPAC_T246","span":{"begin":2,"end":8},"obj":"\"http://rdf.glycoinfo.org/glycan/G70070AY\""},{"id":"GlycanIUPAC_T247","span":{"begin":313,"end":319},"obj":"\"http://rdf.glycoinfo.org/glycan/G70070AY\""},{"id":"GlycanIUPAC_T248","span":{"begin":368,"end":374},"obj":"\"http://rdf.glycoinfo.org/glycan/G70070AY\""},{"id":"GlycanIUPAC_T249","span":{"begin":1020,"end":1026},"obj":"\"http://rdf.glycoinfo.org/glycan/G70070AY\""},{"id":"GlycanIUPAC_T250","span":{"begin":1154,"end":1160},"obj":"\"http://rdf.glycoinfo.org/glycan/G70070AY\""},{"id":"GlycanIUPAC_T251","span":{"begin":1406,"end":1412},"obj":"\"http://rdf.glycoinfo.org/glycan/G70070AY\""},{"id":"GlycanIUPAC_T252","span":{"begin":1478,"end":1484},"obj":"\"http://rdf.glycoinfo.org/glycan/G70070AY\""},{"id":"GlycanIUPAC_T253","span":{"begin":2,"end":8},"obj":"\"http://rdf.glycoinfo.org/glycan/G78792WC\""},{"id":"GlycanIUPAC_T254","span":{"begin":313,"end":319},"obj":"\"http://rdf.glycoinfo.org/glycan/G78792WC\""},{"id":"GlycanIUPAC_T255","span":{"begin":368,"end":374},"obj":"\"http://rdf.glycoinfo.org/glycan/G78792WC\""},{"id":"GlycanIUPAC_T256","span":{"begin":1020,"end":1026},"obj":"\"http://rdf.glycoinfo.org/glycan/G78792WC\""},{"id":"GlycanIUPAC_T257","span":{"begin":1154,"end":1160},"obj":"\"http://rdf.glycoinfo.org/glycan/G78792WC\""},{"id":"GlycanIUPAC_T258","span":{"begin":1406,"end":1412},"obj":"\"http://rdf.glycoinfo.org/glycan/G78792WC\""},{"id":"GlycanIUPAC_T259","span":{"begin":1478,"end":1484},"obj":"\"http://rdf.glycoinfo.org/glycan/G78792WC\""},{"id":"GlycanIUPAC_T260","span":{"begin":2,"end":8},"obj":"\"http://rdf.glycoinfo.org/glycan/G25238AV\""},{"id":"GlycanIUPAC_T261","span":{"begin":313,"end":319},"obj":"\"http://rdf.glycoinfo.org/glycan/G25238AV\""},{"id":"GlycanIUPAC_T262","span":{"begin":368,"end":374},"obj":"\"http://rdf.glycoinfo.org/glycan/G25238AV\""},{"id":"GlycanIUPAC_T263","span":{"begin":1020,"end":1026},"obj":"\"http://rdf.glycoinfo.org/glycan/G25238AV\""},{"id":"GlycanIUPAC_T264","span":{"begin":1154,"end":1160},"obj":"\"http://rdf.glycoinfo.org/glycan/G25238AV\""},{"id":"GlycanIUPAC_T265","span":{"begin":1406,"end":1412},"obj":"\"http://rdf.glycoinfo.org/glycan/G25238AV\""},{"id":"GlycanIUPAC_T266","span":{"begin":1478,"end":1484},"obj":"\"http://rdf.glycoinfo.org/glycan/G25238AV\""},{"id":"GlycanIUPAC_T267","span":{"begin":2,"end":8},"obj":"\"http://rdf.glycoinfo.org/glycan/G40510DP\""},{"id":"GlycanIUPAC_T268","span":{"begin":313,"end":319},"obj":"\"http://rdf.glycoinfo.org/glycan/G40510DP\""},{"id":"GlycanIUPAC_T269","span":{"begin":368,"end":374},"obj":"\"http://rdf.glycoinfo.org/glycan/G40510DP\""},{"id":"GlycanIUPAC_T270","span":{"begin":1020,"end":1026},"obj":"\"http://rdf.glycoinfo.org/glycan/G40510DP\""},{"id":"GlycanIUPAC_T271","span":{"begin":1154,"end":1160},"obj":"\"http://rdf.glycoinfo.org/glycan/G40510DP\""},{"id":"GlycanIUPAC_T272","span":{"begin":1406,"end":1412},"obj":"\"http://rdf.glycoinfo.org/glycan/G40510DP\""},{"id":"GlycanIUPAC_T273","span":{"begin":1478,"end":1484},"obj":"\"http://rdf.glycoinfo.org/glycan/G40510DP\""},{"id":"GlycanIUPAC_T274","span":{"begin":2,"end":8},"obj":"\"http://rdf.glycoinfo.org/glycan/G61120TK\""},{"id":"GlycanIUPAC_T275","span":{"begin":313,"end":319},"obj":"\"http://rdf.glycoinfo.org/glycan/G61120TK\""},{"id":"GlycanIUPAC_T276","span":{"begin":368,"end":374},"obj":"\"http://rdf.glycoinfo.org/glycan/G61120TK\""},{"id":"GlycanIUPAC_T277","span":{"begin":1020,"end":1026},"obj":"\"http://rdf.glycoinfo.org/glycan/G61120TK\""},{"id":"GlycanIUPAC_T278","span":{"begin":1154,"end":1160},"obj":"\"http://rdf.glycoinfo.org/glycan/G61120TK\""},{"id":"GlycanIUPAC_T279","span":{"begin":1406,"end":1412},"obj":"\"http://rdf.glycoinfo.org/glycan/G61120TK\""},{"id":"GlycanIUPAC_T280","span":{"begin":1478,"end":1484},"obj":"\"http://rdf.glycoinfo.org/glycan/G61120TK\""},{"id":"GlycanIUPAC_T281","span":{"begin":2,"end":8},"obj":"\"http://rdf.glycoinfo.org/glycan/G41342KV\""},{"id":"GlycanIUPAC_T282","span":{"begin":313,"end":319},"obj":"\"http://rdf.glycoinfo.org/glycan/G41342KV\""},{"id":"GlycanIUPAC_T283","span":{"begin":368,"end":374},"obj":"\"http://rdf.glycoinfo.org/glycan/G41342KV\""},{"id":"GlycanIUPAC_T284","span":{"begin":1020,"end":1026},"obj":"\"http://rdf.glycoinfo.org/glycan/G41342KV\""},{"id":"GlycanIUPAC_T285","span":{"begin":1154,"end":1160},"obj":"\"http://rdf.glycoinfo.org/glycan/G41342KV\""},{"id":"GlycanIUPAC_T286","span":{"begin":1406,"end":1412},"obj":"\"http://rdf.glycoinfo.org/glycan/G41342KV\""},{"id":"GlycanIUPAC_T287","span":{"begin":1478,"end":1484},"obj":"\"http://rdf.glycoinfo.org/glycan/G41342KV\""},{"id":"GlycanIUPAC_T288","span":{"begin":2,"end":8},"obj":"\"http://rdf.glycoinfo.org/glycan/G90703NA\""},{"id":"GlycanIUPAC_T289","span":{"begin":313,"end":319},"obj":"\"http://rdf.glycoinfo.org/glycan/G90703NA\""},{"id":"GlycanIUPAC_T290","span":{"begin":368,"end":374},"obj":"\"http://rdf.glycoinfo.org/glycan/G90703NA\""},{"id":"GlycanIUPAC_T291","span":{"begin":1020,"end":1026},"obj":"\"http://rdf.glycoinfo.org/glycan/G90703NA\""},{"id":"GlycanIUPAC_T292","span":{"begin":1154,"end":1160},"obj":"\"http://rdf.glycoinfo.org/glycan/G90703NA\""},{"id":"GlycanIUPAC_T293","span":{"begin":1406,"end":1412},"obj":"\"http://rdf.glycoinfo.org/glycan/G90703NA\""},{"id":"GlycanIUPAC_T294","span":{"begin":1478,"end":1484},"obj":"\"http://rdf.glycoinfo.org/glycan/G90703NA\""},{"id":"GlycanIUPAC_T295","span":{"begin":2,"end":8},"obj":"\"http://rdf.glycoinfo.org/glycan/G01591HR\""},{"id":"GlycanIUPAC_T296","span":{"begin":313,"end":319},"obj":"\"http://rdf.glycoinfo.org/glycan/G01591HR\""},{"id":"GlycanIUPAC_T297","span":{"begin":368,"end":374},"obj":"\"http://rdf.glycoinfo.org/glycan/G01591HR\""},{"id":"GlycanIUPAC_T298","span":{"begin":1020,"end":1026},"obj":"\"http://rdf.glycoinfo.org/glycan/G01591HR\""},{"id":"GlycanIUPAC_T299","span":{"begin":1154,"end":1160},"obj":"\"http://rdf.glycoinfo.org/glycan/G01591HR\""},{"id":"GlycanIUPAC_T300","span":{"begin":1406,"end":1412},"obj":"\"http://rdf.glycoinfo.org/glycan/G01591HR\""},{"id":"GlycanIUPAC_T301","span":{"begin":1478,"end":1484},"obj":"\"http://rdf.glycoinfo.org/glycan/G01591HR\""},{"id":"GlycanIUPAC_T302","span":{"begin":2,"end":8},"obj":"\"http://rdf.glycoinfo.org/glycan/G56520XN\""},{"id":"GlycanIUPAC_T303","span":{"begin":313,"end":319},"obj":"\"http://rdf.glycoinfo.org/glycan/G56520XN\""},{"id":"GlycanIUPAC_T304","span":{"begin":368,"end":374},"obj":"\"http://rdf.glycoinfo.org/glycan/G56520XN\""},{"id":"GlycanIUPAC_T305","span":{"begin":1020,"end":1026},"obj":"\"http://rdf.glycoinfo.org/glycan/G56520XN\""},{"id":"GlycanIUPAC_T306","span":{"begin":1154,"end":1160},"obj":"\"http://rdf.glycoinfo.org/glycan/G56520XN\""},{"id":"GlycanIUPAC_T307","span":{"begin":1406,"end":1412},"obj":"\"http://rdf.glycoinfo.org/glycan/G56520XN\""},{"id":"GlycanIUPAC_T308","span":{"begin":1478,"end":1484},"obj":"\"http://rdf.glycoinfo.org/glycan/G56520XN\""},{"id":"GlycanIUPAC_T309","span":{"begin":2,"end":8},"obj":"\"http://rdf.glycoinfo.org/glycan/G81830JX\""},{"id":"GlycanIUPAC_T310","span":{"begin":313,"end":319},"obj":"\"http://rdf.glycoinfo.org/glycan/G81830JX\""},{"id":"GlycanIUPAC_T311","span":{"begin":368,"end":374},"obj":"\"http://rdf.glycoinfo.org/glycan/G81830JX\""},{"id":"GlycanIUPAC_T312","span":{"begin":1020,"end":1026},"obj":"\"http://rdf.glycoinfo.org/glycan/G81830JX\""},{"id":"GlycanIUPAC_T313","span":{"begin":1154,"end":1160},"obj":"\"http://rdf.glycoinfo.org/glycan/G81830JX\""},{"id":"GlycanIUPAC_T314","span":{"begin":1406,"end":1412},"obj":"\"http://rdf.glycoinfo.org/glycan/G81830JX\""},{"id":"GlycanIUPAC_T315","span":{"begin":1478,"end":1484},"obj":"\"http://rdf.glycoinfo.org/glycan/G81830JX\""}],"text":"O-GlcNAc transferase inhibits KSHV propagation and modifies replication relevant viral proteins as detected by systematic O-GlcNAcylation analysis.\nO-GlcNAcylation is an inducible, highly dynamic and reversible post-translational modification, mediated by a unique enzyme named O-linked N-acetyl-d-glucosamine (O-GlcNAc) transferase (OGT). In response to nutrients, O-GlcNAc levels are differentially regulated on many cellular proteins involved in gene expression, translation, immune reactions, protein degradation, protein-protein interaction, apoptosis and signal transduction. In contrast to eukaryotic cells, little is known about the role of O-GlcNAcylation in the viral life cycle. Here, we show that the overexpression of the OGT reduces the replication efficiency of Kaposi's sarcoma-associated herpesvirus (KSHV) in a dose-dependent manner. In order to investigate the global impact of O-GlcNAcylation in the KSHV life cycle, we systematically analyzed the 85 annotated KSHV-encoded open reading frames for O-GlcNAc modification. For this purpose, an immunoprecipitation (IP) strategy with three different approaches was carried out and the O-GlcNAc signal of the identified proteins was properly controlled for specificity. Out of the 85 KSHV-encoded proteins, 18 proteins were found to be direct targets for O-GlcNAcylation. Selected proteins were further confirmed by mass spectrometry for O-GlcNAc modification. Correlation of the functional annotation and the O-GlcNAc status of KSHV proteins showed that the predominant targets were proteins involved in viral DNA synthesis and replication. These results indicate that O-GlcNAcylation plays a major role in the regulation of KSHV propagation."}

    mondo_disease

    {"project":"mondo_disease","denotations":[{"id":"T1","span":{"begin":30,"end":34},"obj":"Disease"},{"id":"T2","span":{"begin":777,"end":823},"obj":"Disease"},{"id":"T3","span":{"begin":920,"end":924},"obj":"Disease"},{"id":"T4","span":{"begin":981,"end":985},"obj":"Disease"},{"id":"T5","span":{"begin":1250,"end":1254},"obj":"Disease"},{"id":"T6","span":{"begin":1495,"end":1499},"obj":"Disease"},{"id":"T7","span":{"begin":1692,"end":1696},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0005055"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0005055"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0005055"},{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0005055"},{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0005055"},{"id":"A6","pred":"mondo_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MONDO_0005055"},{"id":"A7","pred":"mondo_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/MONDO_0005055"}],"text":"O-GlcNAc transferase inhibits KSHV propagation and modifies replication relevant viral proteins as detected by systematic O-GlcNAcylation analysis.\nO-GlcNAcylation is an inducible, highly dynamic and reversible post-translational modification, mediated by a unique enzyme named O-linked N-acetyl-d-glucosamine (O-GlcNAc) transferase (OGT). In response to nutrients, O-GlcNAc levels are differentially regulated on many cellular proteins involved in gene expression, translation, immune reactions, protein degradation, protein-protein interaction, apoptosis and signal transduction. In contrast to eukaryotic cells, little is known about the role of O-GlcNAcylation in the viral life cycle. Here, we show that the overexpression of the OGT reduces the replication efficiency of Kaposi's sarcoma-associated herpesvirus (KSHV) in a dose-dependent manner. In order to investigate the global impact of O-GlcNAcylation in the KSHV life cycle, we systematically analyzed the 85 annotated KSHV-encoded open reading frames for O-GlcNAc modification. For this purpose, an immunoprecipitation (IP) strategy with three different approaches was carried out and the O-GlcNAc signal of the identified proteins was properly controlled for specificity. Out of the 85 KSHV-encoded proteins, 18 proteins were found to be direct targets for O-GlcNAcylation. Selected proteins were further confirmed by mass spectrometry for O-GlcNAc modification. Correlation of the functional annotation and the O-GlcNAc status of KSHV proteins showed that the predominant targets were proteins involved in viral DNA synthesis and replication. These results indicate that O-GlcNAcylation plays a major role in the regulation of KSHV propagation."}

    NCBITAXON

    {"project":"NCBITAXON","denotations":[{"id":"T1","span":{"begin":30,"end":34},"obj":"OrganismTaxon"},{"id":"T2","span":{"begin":777,"end":816},"obj":"OrganismTaxon"},{"id":"T3","span":{"begin":818,"end":822},"obj":"OrganismTaxon"},{"id":"T4","span":{"begin":920,"end":924},"obj":"OrganismTaxon"},{"id":"T5","span":{"begin":981,"end":985},"obj":"OrganismTaxon"},{"id":"T6","span":{"begin":1250,"end":1254},"obj":"OrganismTaxon"},{"id":"T7","span":{"begin":1495,"end":1499},"obj":"OrganismTaxon"},{"id":"T8","span":{"begin":1692,"end":1696},"obj":"OrganismTaxon"}],"attributes":[{"id":"A1","pred":"db_id","subj":"T1","obj":"37296"},{"id":"A2","pred":"db_id","subj":"T2","obj":"37296"},{"id":"A3","pred":"db_id","subj":"T3","obj":"37296"},{"id":"A4","pred":"db_id","subj":"T4","obj":"37296"},{"id":"A5","pred":"db_id","subj":"T5","obj":"37296"},{"id":"A6","pred":"db_id","subj":"T6","obj":"37296"},{"id":"A7","pred":"db_id","subj":"T7","obj":"37296"},{"id":"A8","pred":"db_id","subj":"T8","obj":"37296"}],"text":"O-GlcNAc transferase inhibits KSHV propagation and modifies replication relevant viral proteins as detected by systematic O-GlcNAcylation analysis.\nO-GlcNAcylation is an inducible, highly dynamic and reversible post-translational modification, mediated by a unique enzyme named O-linked N-acetyl-d-glucosamine (O-GlcNAc) transferase (OGT). In response to nutrients, O-GlcNAc levels are differentially regulated on many cellular proteins involved in gene expression, translation, immune reactions, protein degradation, protein-protein interaction, apoptosis and signal transduction. In contrast to eukaryotic cells, little is known about the role of O-GlcNAcylation in the viral life cycle. Here, we show that the overexpression of the OGT reduces the replication efficiency of Kaposi's sarcoma-associated herpesvirus (KSHV) in a dose-dependent manner. In order to investigate the global impact of O-GlcNAcylation in the KSHV life cycle, we systematically analyzed the 85 annotated KSHV-encoded open reading frames for O-GlcNAc modification. For this purpose, an immunoprecipitation (IP) strategy with three different approaches was carried out and the O-GlcNAc signal of the identified proteins was properly controlled for specificity. Out of the 85 KSHV-encoded proteins, 18 proteins were found to be direct targets for O-GlcNAcylation. Selected proteins were further confirmed by mass spectrometry for O-GlcNAc modification. Correlation of the functional annotation and the O-GlcNAc status of KSHV proteins showed that the predominant targets were proteins involved in viral DNA synthesis and replication. These results indicate that O-GlcNAcylation plays a major role in the regulation of KSHV propagation."}

    Glycosmos15-GlycoEpitope

    {"project":"Glycosmos15-GlycoEpitope","denotations":[{"id":"T1","span":{"begin":0,"end":8},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"},{"id":"T2","span":{"begin":311,"end":319},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"},{"id":"T3","span":{"begin":366,"end":374},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"},{"id":"T4","span":{"begin":1018,"end":1026},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"},{"id":"T5","span":{"begin":1152,"end":1160},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"},{"id":"T6","span":{"begin":1404,"end":1412},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"},{"id":"T7","span":{"begin":1476,"end":1484},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"}],"attributes":[{"id":"A1","pred":"glycoepitope_id","subj":"T1","obj":"http://www.glycoepitope.jp/epitopes/EP0004"},{"id":"A2","pred":"glycoepitope_id","subj":"T2","obj":"http://www.glycoepitope.jp/epitopes/EP0004"},{"id":"A3","pred":"glycoepitope_id","subj":"T3","obj":"http://www.glycoepitope.jp/epitopes/EP0004"},{"id":"A4","pred":"glycoepitope_id","subj":"T4","obj":"http://www.glycoepitope.jp/epitopes/EP0004"},{"id":"A5","pred":"glycoepitope_id","subj":"T5","obj":"http://www.glycoepitope.jp/epitopes/EP0004"},{"id":"A6","pred":"glycoepitope_id","subj":"T6","obj":"http://www.glycoepitope.jp/epitopes/EP0004"},{"id":"A7","pred":"glycoepitope_id","subj":"T7","obj":"http://www.glycoepitope.jp/epitopes/EP0004"}],"text":"O-GlcNAc transferase inhibits KSHV propagation and modifies replication relevant viral proteins as detected by systematic O-GlcNAcylation analysis.\nO-GlcNAcylation is an inducible, highly dynamic and reversible post-translational modification, mediated by a unique enzyme named O-linked N-acetyl-d-glucosamine (O-GlcNAc) transferase (OGT). In response to nutrients, O-GlcNAc levels are differentially regulated on many cellular proteins involved in gene expression, translation, immune reactions, protein degradation, protein-protein interaction, apoptosis and signal transduction. In contrast to eukaryotic cells, little is known about the role of O-GlcNAcylation in the viral life cycle. Here, we show that the overexpression of the OGT reduces the replication efficiency of Kaposi's sarcoma-associated herpesvirus (KSHV) in a dose-dependent manner. In order to investigate the global impact of O-GlcNAcylation in the KSHV life cycle, we systematically analyzed the 85 annotated KSHV-encoded open reading frames for O-GlcNAc modification. For this purpose, an immunoprecipitation (IP) strategy with three different approaches was carried out and the O-GlcNAc signal of the identified proteins was properly controlled for specificity. Out of the 85 KSHV-encoded proteins, 18 proteins were found to be direct targets for O-GlcNAcylation. Selected proteins were further confirmed by mass spectrometry for O-GlcNAc modification. Correlation of the functional annotation and the O-GlcNAc status of KSHV proteins showed that the predominant targets were proteins involved in viral DNA synthesis and replication. These results indicate that O-GlcNAcylation plays a major role in the regulation of KSHV propagation."}

    Anatomy-UBERON

    {"project":"Anatomy-UBERON","denotations":[{"id":"T1","span":{"begin":597,"end":613},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CL_0000255"}],"text":"O-GlcNAc transferase inhibits KSHV propagation and modifies replication relevant viral proteins as detected by systematic O-GlcNAcylation analysis.\nO-GlcNAcylation is an inducible, highly dynamic and reversible post-translational modification, mediated by a unique enzyme named O-linked N-acetyl-d-glucosamine (O-GlcNAc) transferase (OGT). In response to nutrients, O-GlcNAc levels are differentially regulated on many cellular proteins involved in gene expression, translation, immune reactions, protein degradation, protein-protein interaction, apoptosis and signal transduction. In contrast to eukaryotic cells, little is known about the role of O-GlcNAcylation in the viral life cycle. Here, we show that the overexpression of the OGT reduces the replication efficiency of Kaposi's sarcoma-associated herpesvirus (KSHV) in a dose-dependent manner. In order to investigate the global impact of O-GlcNAcylation in the KSHV life cycle, we systematically analyzed the 85 annotated KSHV-encoded open reading frames for O-GlcNAc modification. For this purpose, an immunoprecipitation (IP) strategy with three different approaches was carried out and the O-GlcNAc signal of the identified proteins was properly controlled for specificity. Out of the 85 KSHV-encoded proteins, 18 proteins were found to be direct targets for O-GlcNAcylation. Selected proteins were further confirmed by mass spectrometry for O-GlcNAc modification. Correlation of the functional annotation and the O-GlcNAc status of KSHV proteins showed that the predominant targets were proteins involved in viral DNA synthesis and replication. These results indicate that O-GlcNAcylation plays a major role in the regulation of KSHV propagation."}

    GlyCosmos15-HP

    {"project":"GlyCosmos15-HP","denotations":[{"id":"T1","span":{"begin":777,"end":793},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"HP:0100726"}],"namespaces":[{"prefix":"HP","uri":"http://purl.obolibrary.org/obo/HP_"}],"text":"O-GlcNAc transferase inhibits KSHV propagation and modifies replication relevant viral proteins as detected by systematic O-GlcNAcylation analysis.\nO-GlcNAcylation is an inducible, highly dynamic and reversible post-translational modification, mediated by a unique enzyme named O-linked N-acetyl-d-glucosamine (O-GlcNAc) transferase (OGT). In response to nutrients, O-GlcNAc levels are differentially regulated on many cellular proteins involved in gene expression, translation, immune reactions, protein degradation, protein-protein interaction, apoptosis and signal transduction. In contrast to eukaryotic cells, little is known about the role of O-GlcNAcylation in the viral life cycle. Here, we show that the overexpression of the OGT reduces the replication efficiency of Kaposi's sarcoma-associated herpesvirus (KSHV) in a dose-dependent manner. In order to investigate the global impact of O-GlcNAcylation in the KSHV life cycle, we systematically analyzed the 85 annotated KSHV-encoded open reading frames for O-GlcNAc modification. For this purpose, an immunoprecipitation (IP) strategy with three different approaches was carried out and the O-GlcNAc signal of the identified proteins was properly controlled for specificity. Out of the 85 KSHV-encoded proteins, 18 proteins were found to be direct targets for O-GlcNAcylation. Selected proteins were further confirmed by mass spectrometry for O-GlcNAc modification. Correlation of the functional annotation and the O-GlcNAc status of KSHV proteins showed that the predominant targets were proteins involved in viral DNA synthesis and replication. These results indicate that O-GlcNAcylation plays a major role in the regulation of KSHV propagation."}

    Glycosmos15-CL

    {"project":"Glycosmos15-CL","denotations":[{"id":"T1","span":{"begin":597,"end":613},"obj":"Cell"}],"attributes":[{"id":"A1","pred":"cl_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CL:0000255"}],"text":"O-GlcNAc transferase inhibits KSHV propagation and modifies replication relevant viral proteins as detected by systematic O-GlcNAcylation analysis.\nO-GlcNAcylation is an inducible, highly dynamic and reversible post-translational modification, mediated by a unique enzyme named O-linked N-acetyl-d-glucosamine (O-GlcNAc) transferase (OGT). In response to nutrients, O-GlcNAc levels are differentially regulated on many cellular proteins involved in gene expression, translation, immune reactions, protein degradation, protein-protein interaction, apoptosis and signal transduction. In contrast to eukaryotic cells, little is known about the role of O-GlcNAcylation in the viral life cycle. Here, we show that the overexpression of the OGT reduces the replication efficiency of Kaposi's sarcoma-associated herpesvirus (KSHV) in a dose-dependent manner. In order to investigate the global impact of O-GlcNAcylation in the KSHV life cycle, we systematically analyzed the 85 annotated KSHV-encoded open reading frames for O-GlcNAc modification. For this purpose, an immunoprecipitation (IP) strategy with three different approaches was carried out and the O-GlcNAc signal of the identified proteins was properly controlled for specificity. Out of the 85 KSHV-encoded proteins, 18 proteins were found to be direct targets for O-GlcNAcylation. Selected proteins were further confirmed by mass spectrometry for O-GlcNAc modification. Correlation of the functional annotation and the O-GlcNAc status of KSHV proteins showed that the predominant targets were proteins involved in viral DNA synthesis and replication. These results indicate that O-GlcNAcylation plays a major role in the regulation of KSHV propagation."}